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ABSTRACT 
 
Bacteriocins from lactic acid bacteria are small peptides that show antimicrobial activity 
towards other bacteria, generally strains closely related to the producer. As target 
microorganisms include pathogens and many bacteria responsible of the food spoilage, 
the interest in bacteriocins as food biopreservatives is greatly increased in recent years.  
Three lactic acid bacteria strains were screened to evaluate their ability to produce 
bacteriocins active towards pathogens and, therefore, potentially interesting in food 
industry. One of them (Enterococcus casseliflavus CGA1), industrial strain isolated by 
“salami” processing, was able to produce a small enterocin with strong activity versus 
Listeria monocytogenes, a pathogen that causes listeriosis. In the prospect of a cost 
effective application of this peptide in food industry, a biotechnological process 
consisting of a fed-batch fermentation strategy and a purification procedure based on 
membranes was developed and scaled up.  
First, in order to satisfy economical constraints for the industrial implementation, a 
growth medium suitable for microorganism growth and enterocin production was 
optimized. Particularly, the best complex nitrogen nutrient was identified and the 
concentrations of carbon and nitrogen sources were decreased evaluating the effect on 
bacteriocin activity. The optimized medium was used to grow the microorganism in 
batch fermentations. Growth parameters were properly identified through the 
characterization of the growth curve and the kinetics of glucose consumption and lactic 
acid production. The kinetics of bacteriocin production was also defined and compared 
with the growth curve, showing that the enterocin is a growth-related product. 
Due to this, the biomass production and, therefore, the bacteriocin activity was improved 
through exploiting modern technologies of high cell density fermentations. Different fed-
batch strategies were tried. Particularly, batch data of yield and glucose consumption 
were used to implement a fed-batch profile based on continuous feeding of substrate 
into bioreactor. This process allowed to improve about eight fold both biomass 
concentration and enterocin production. It was also scaled up to a pilot plant of 100 L, 
showing high reproducibility in terms of microorganism growth and bacteriocin titer.  
In order to purify the product from the fermentation broth, an innovative downstream 
processing based on two ultrafiltration steps was developed and compared with 
traditional procedures, using large amounts of organic solvents. Membrane processes 
allowed to obtain the best product yield and purification fold. A spectrum activity of the 
purified product, comprising starter cultures and pathogens, was also established. 
Product was active towards dairy starter cultures, but not towards the ones used in meat 
processing. The results obtained seem to confirm the effective applicability of the 
product as natural additive to improve meat microbiological safety.   
The same indicator strains were used to assay the antimicrobial activity of two 
lactobacilli strains, Lactobacillus plantarum DSM 12028 and Lactobacillus crispatus L1. 
Both strains were able to inhibit pathogenic bacteria, as Staphilococcus aureus and 
Streptococcus agalactiae. Therefore, they seem to be good candidates for the 
production of bacteriocins of biotechnological interest. The effect of different 
concentrations of complex nitrogen source on bacteriocin production was studied in 
flask experiments, as well as batch fermentations were performed in order to enhance 
bacteriocin activity. Particularly for L. plantarum DSM 12028, the controlled fermentation 
environment allowed to improve significantly the production of the metabolite of interest.    
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RIASSUNTO 
 
Negli ultimi anni si è assistito ad un crescente sforzo finalizzato alla ricerca di nuovi 
prodotti deputati alla protezione degli alimenti dalla contaminazione microbica. 
Attualmente esiste in commercio una grande varietà di prodotti chimici con proprietà 
preservanti ampiamente utilizzata nell’industria per la conservazione degli alimenti. 
Nonostante la conservazione con sostanze chimiche di sintesi fornisca molti vantaggi, i 
consumatori sono sempre più attenti ai loro eventuali effetti tossici. Per tale motivo, i 
produttori si stanno sempre più indirizzando verso la ricerca di sostanze additive 
alternative, possibilmente di origine naturale, per ridurre o evitare del tutto i conservanti 
chimici tradizionali. Non è un caso, dunque, che negli ultimi anni grande attenzione si 
sta rivolgendo alla messa a punto di svariati approcci di conservazione biologica degli 
alimenti. 
Per definizione, essa si riferisce all’utilizzo di microrganismi antagonisti (colture 
protettive) o dei loro prodotti metabolici (biopreservanti) per inibire o distruggere 
microrganismi indesiderati negli alimenti, pertanto aumentandone la sicurezza 
microbiologica ed estendendone la shelflife. La maggior parte dei moderni approcci di 
conservazione biologica prevedono l’utilizzo mirato e consapevole di batteri lattici o dei 
loro prodotti metabolici. Essi sono stati infatti utilizzati per secoli nella fermentazione e 
processazione di svariati alimenti, dai prodotti caseari alle carni, dai cereali ai prodotti 
vegetali. In questi alimenti, essi producono una grande  varietà di composti che 
contribuiscono alla determinazione dell’aroma, colore e consistenza. Per questa loro 
associazione con il cibo e la lunga tradizione di batteri food-grade, molti di essi 
posseggono lo status di microrganismi GRAS (Generally Regarded As Safe). Negli 
alimenti in cui sono presenti, inoltre, essi forniscono anche un grande effetto 
preservante, dovuto alla capacità di produrre un vero e proprio arsenale di composti ad 
attività antimicrobica. Questi comprendono metaboliti a basso peso molecolare come 
anidride carbonica, perossido d’idrogeno e diacetile; acidi organici come acido lattico ed 
acido acetico; enzimi come lisozima e lattoperossidasi e, soprattutto, batteriocine. 
Le batteriocine prodotte da batteri lattici possono essere definite come peptidi o piccole 
proteine, sintetizzate per via ribosomale e secrete nel mezzo extracellulare, che 
posseggono attività inibitoria verso batteri Gram positivi, in particolare ceppi 
strettamente correlati al microrganismo produttore. Poiché il loro spettro inibitorio 
comprende patogeni degli alimenti, nonché microrganismi responsabili del food 
spoilage, esse hanno il potenziale di additivi naturali degli alimenti nell’ottica di un 
approccio innovativo di conservazione biologica. Tipici bersagli delle batteriocine sono 
infatti microrganismi quali Listeria monocytogenes e Staphilococcus aureus, tipicamente 
associati a malattie di diversa natura, nonché batteri sporigeni come specie di Bacillus e 
Clostridium. Questi peptidi espletano la loro azione formando pori sulla membrana delle 
cellule bersaglio, quindi privandole del corretto potenziale transmembrana e gradiente di 
pH e causando la fuoriuscita di materiale cellulare.    
Sulla base di caratteristiche prettamente strutturali, le batteriocine vengono 
tradizionalmente suddivise in tre classi. Alla classe I appartengono peptidi contententi 
amminoacidi inusuali come lantionina, β-metil-lantionina e deidroalanina; per questa loro 
caratteristica vengono anche chiamati lantibiotici. Il principale esempio di lantibiotico è 
sicuramente la nisina. 
Alla classe II appartengono piccoli peptidi (PM<10 kDa), stabili al calore e privi di 
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lantionina e altri amminoacidi atipici. Questa classe è tradizionalmente suddivisa in tre 
sottogruppi. Alla classe IIa appartengono molte batteriocine con spiccata attività anti-
Listeria, quindi di grande interesse applicativo.  
La classe III, infine, è costituita da prodotti, ancora poco caratterizzati, ad alto PM (>30 
kDa), labili al calore e di minor interesse applicativo. 
L’impiego di batteriocine come biopreservanti, soprattutto nisina e peptidi di classe IIa, è 
stato ampiamente valutato, e si sta dimostrando una strategia efficace nel controllo di 
microrganismi patogeni. I principali approcci di conservazione biologica che sfruttano 
batteriocine sono: 
1) inoculo dell’alimento con un batterio lattico (coltura protettiva) produttore di 
batteriocina (produzione in situ); 
2) aggiunta diretta all’alimento di una batteriocina purificata o semi-purificata; 
3) utilizzo di un prodotto precedentemente fermentato con un ceppo produttore di 
batteriocina. 
La letteratura brevettuale è ricca di esempi che sfruttano questi metodi al fine di 
controllare la contaminazione dell’alimento da microrganismi patogeni e responsabili del 
deterioramento. I sistemi alimentari presi in considerazione spaziano da prodotti caseari 
(es. yogurt, latte e formaggi) a carni (es. salsicce e salami) a prodotti ittici (es. salmone) 
e vegetali (es. olive). Nonostante l’alto numero di lavori e brevetti prodotti, fino ad ora 
solo la nisina ha trovato reale applicazione ed è effettivamente prodotta attraverso un 
processo industriale e commercializzata. Questo è un peptide di 34 amminoacidi 
prodotto da ceppi di Lactococcus lactis ed è il rappresentante meglio studiato dei 
lantibiotici. La nisina normalmente ha attività inibitoria solo verso batteri Gram positivi, 
tra cui svariati batteri lattici, patogeni come Listeria, Staphylococcus, e Mycobacterium, 
e batteri sporigeni come Bacillus and Clostridium. Attualmente il suo utilizzo come 
biopreservante degli alimenti è accettato in circa 50 nazioni. 
La carenza di altre effettive applicazioni commerciali di batteriocine è dovuta a problemi 
insiti nella tipologia di approccio considerato; in particolare le metodiche basate 
sull’utilizzo di colture protettive, sebbene più economiche rispetto all’utilizzo diretto di 
batteriocine come biopreservanti, sono limitate da un numero di fattori. In primo luogo, lo 
specifico ambiente dell’alimento (es. pH, temperatura, nutrienti) può non essere idoneo 
alla produzione della batteriocina. Inoltre, fattori limitanti possono essere la perdita 
spontanea della capacità di produrre il peptide e/o l’incapacità di secernere sufficienti 
quantità di prodotto tali da inibire i microrganismi indesiderati. Altre limiti sono la 
possibile contaminazione da fagi della coltura produttrice e l’antagonismo esercitato da 
altri batteri presenti nell’alimento, con conseguente inibizione della crescita del 
produttore e quindi della produzione di batteriocina. Vanno infine presi in considerazione 
eventuali effetti dannosi della coltura protettiva sulle qualità dell’alimento e sulla salute 
del consumatore (es. dovuti a produzione di tossine o ammine biogeniche). 
Per via di questi limiti, gli approcci preferiti e più studiati sono quelli basati sull’aggiunta 
diretta di preparazioni purificate o semi-purificate della batteriocina di interesse. In 
questo caso la principale limitazione è dovuta alla mancanza di processi fermentativi 
idonei su larga scala necessari all’ottenimento di sufficienti quantità di prodotto. Inoltre, 
affinchè l’uso commerciale diventi effettivo, una strategia economicamente vantaggiosa 
per la purificazione della batteriocina dal brodo di fermentazione necessita di essere 
implementata ed ottimizzata.    
Questo progetto di dottorato è nato proprio nella prospettiva di sviluppare processi 
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idonei alla produzione e purificazione su larga scala di batteriocine di interesse 
applicativo. In particolare tre batteri lattici, uno appartenente al genere Enterococcus e 
due al genere Lactobacillus, sono stati sottoposti a test di attività finalizzati a valutare la 
loro capacità di produrre batteriocine di interesse applicativo. Uno di essi, Enterococcus 
casseliflavus CGA1, si è mostrato capace di produrre un peptide con forte attività verso 
Listeria monocytogenes, candidandosi come microrganismo produttore di una 
batteriocina con potenziale applicativo quale biopreservante delle carni. Questo 
microrganismo, fornito da un’industria attiva nel settore alimentare, è stato infatti isolato 
da salami, dove L. monocytogenes comunemente espleta la sua attività patogenica.  
Gli enterococchi sono batteri lattici isolati dal tratto intestinale dell’uomo e di una varietà 
di animali, nonché da diversi alimenti, soprattutto formaggi dell’area mediterranea e 
carni, quali salsicce fermentate e salami. E’ interessante notare come molti ceppi 
enterococcali producano batteriocine, denominate enterocine, generalmente 
appartenenti alla classe II. Esse sono spesso attive verso altri enterococchi, ceppi di L. 
monocytogenes e specie di Clostridium. L’attività anti-Listeria può essere spiegata 
considerando la stretta parentela filogenetica esistente tra i due generi. Sulla base di 
questa forte attività, metodiche di conservazione che utilizzano enterococchi o 
enterocine sono molto promettenti. In quest’ottica, un processo di produzione 
fermentativa e purificazione dell’enterocina da E. casseliflavus CGA1 è stato sviluppato, 
ottimizzato e sottoposto a studi di scale-up. 
La prima parte del lavoro è consistita nell’ottimizzazione della composizione di un 
terreno di coltura idoneo alla crescita del microrganismo e alla produzione di enterocina. 
E’ infatti noto che la produzione di batteriocina è fortemente influenzata dalle condizioni 
di cultura, come pH, temperatura e composizione del mezzo. Solitamente condizioni che 
favoriscono la produzione di biomassa migliorano anche la produzione di batteriocina; 
pertanto, elevate rese di batteriocina sono state osservate in terreni ricchi, come MRS o 
MRS addizionato con ulteriori fonti complesse, come estratto di lievito, di malto o di 
carne. I limiti di questi terreni sono l’elevato costo e la composizione ricca tale da poter 
causare problemi di contaminazione nelle successive fasi di purificazione del prodotto; 
questi fattori ne rendono problematico l’utilizzo su scala industriale. Pertanto, fin 
dall’inizio ci si è orientati su un terreno a composizione semidefinita contenente una sola 
fonte complessa, quella di azoto fornito sotto forma di amminoacidi e peptidi. 
Esperimenti in beuta sono stati quindi effettuati allo scopo di individuare, tra una rosa di 
diversi peptoni industriali a basso costo, quello ottimale in termini di produzione di 
batteriocina. I risultati migliori sono stati ottenuti con i due peptoni di soia esaminati 
(indicati dalle sigle A2SC e E110): entrambi hanno permesso di ottenere, dopo circa 8 h 
di crescita, un massimo di attività di batteriocina di 80 BU (Bacteriocin Units)·mL-1. In 
termini di produzione specifica di batteriocina, che rappresenta la concentrazione di 
batteriocina prodotta per unità di biomassa (o densità ottica a 600 nm), il miglior dato è 
stato osservato in presenza di peptone di soia A2SC (20.5 BU·mL-1·OD-1). Come ci si 
poteva aspettare, un’alta produzione specifica (22.7 BU·mL-1·OD-1) è stata registrata 
anche quando il microrganismo è stato cresciuto in MRS. 
Allo scopo di ridurre i costi del terreno, sono stati effettuati ulteriori esperimenti in beuta 
in cui il microrganismo è stato cresciuto in terreno semidefinito contenente diverse 
concentrazioni (da 20 a 5 g·L-1) di glucosio (fonte di carbonio e di energia) e di peptone 
di soia A2SC, i  due principali componenti del mezzo. Una riduzione della produzione di 
biomassa del 30 % rispetto alle condizioni iniziali (20 g·L-1 per entrambi i nutrienti) è 
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stata osservata nei terreni contenenti 5 g·L-1 di peptone di soia A2SC, 
indipendentemente dalla concentrazione di glucosio (20, 10 o 5 g·L-1). Naturalmente, 
minore è risultata anche l’attività di enterocina, che da 80 è scesa a 60 BU·mL-1. Un dato 
invece interessante è che la produzione specifica di peptide aumenta nei terreni più 
poveri: un valore di 22.9 BU·mL-1·OD-1 è stato registrato nel terreno contenente un 
quarto delle concentrazioni iniziali dei due componenti. Essendosi quindi rivelato idoneo 
alla produzione ed economicamente vantaggioso, questo terreno è stato scelto e 
utilizzato per la crescita E. casseliflavus CGA1 nei successivi esperimenti di 
fermentazione. 
Questi ultimi sono stati inizialmente effettuati in un fermentatore da 2 L esercito in 
modalità batch. E’ stato possibile caratterizzare la curva di crescita del ceppo e di 
compararla alle cinetiche di consumo di glucosio e produzione di acido lattico. In tal 
modo parametri chiave, quali velocità di crescita specifica (μ) e rese di biomassa e di 
acido lattico su glucosio (Yxs e Yps) sono stati determinati. Il valore ottenuto di Yps (0.89 
g·g-1) mostra come il microrganismo intraprenda un metabolismo fermentativo di tipo 
omolattico quando cresciuto su glucosio. La cinetica di produzione di enterocina è stata 
anche caratterizzata: la produzione comincia appena la coltura entra in fase 
esponenziale fino a raggiungere un massimo di 80 BU·mL-1 a 6 h di crescita (picco 
dell’esponenziale), e rimanere costante durante la fase stazionaria; un decremento 
dell’attività si osserva in tarda fase stazionaria (24 h). Questo andamento riflette il 
carattere di tipico metabolita primario del prodotto, come del resto osservato per molte 
altre batteriocine. Anche la diminuzione di attività in fase stazionaria è riportata in 
letteratura e viene spiegata come conseguenza di inattivazione proteolitica e 
adsorbimento del peptide alla superfiicie cellulare del produttore, in maniera dipendente 
dal pH. Questo fenomeno è infatti prevalente a pH neutri (6-7), che sono anche i pH 
tipici di crescita dei batteri lattici, ed è minimo a pH acidi (2-3). 
Essendo dunque la batteriocina un metabolita correlato alla crescita, maggiore è la 
produzione di biomassa, maggiore sarà l’attività di peptide. Pertanto, il passo 
successivo è consistito nel ricorso a strategie fed-batch di fermentazione per ottenere 
alte densità cellulari del microrganismo. Due differenti strategie di alimentazione sono 
state implementate. Nel primo caso, impulsi di terreno concentrato a tempi predefiniti e 
tali da restituire la concentrazione iniziale di ciascun componente hanno permesso di 
migliorare la produzione di biomassa e di enterocina (fino a 160 BU·mL-1 
nell’esperimento con tre impulsi), ma la produzione specifica è risultata minore rispetto a 
quella osservata in batch. La seconda strategia è consistita nello sviluppo di un profilo 
continuo di alimentazione di substrato limitante (glucosio) all’interno del bioreattore, a 
partire dalla fine della fase batch. Questo profilo è stato determinato dai valori di velocità 
di crescita, resa di biomassa su substrato e consumo di glucosio ottenuti in batch. Con 
questa strategia una concentrazione finale (30 h) di biomassa di 11.6 g·L-1 è stata 
ottenuta, corrispondente ad un miglioramento di 8.5 volte di quella ottenuta in  batch. 
Soprattutto, anche la produzione di enterocina, pari a 640 BU·mL-1, è stata 
sensibilmente migliorata (8 volte), così come la produzione specifica (30.4 BU·mL-1·OD-
1) rispetto al batch. Sia in termini di biomassa che produzione di batteriocina, i dati 
ottenuti sulla piccola scala (2 L) sono stati riprodotti mediante una strategia di scale-up 
lineare anche su 15 e 100 L, a dimostrazione della validità e robustezza del processo 
anche su scale superiori. 
Un processo biotecnologico economicamente attuabile richiede anche una idonea 
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strategia di purificazione del prodotto dal brodo di fermentazione. Le batteriocine 
vengono generalmente purificate mediante passaggi successivi di centrifugazione per 
allontanare le cellule, precipitazione in solfato d’ammonio per concentrare il peptide e 
uno o più passaggi cromatografici (soprattutto scambio ionico e fase inversa) per 
purificarlo ad omogeneità. Queste metodiche vanno bene per piccoli volumi (≤ 1 L), ma 
non sono proponibili per i grandi volumi di una produzione industriale. Metodi basati 
sull’utilizzo di solventi organici sono stati in questo caso messi a punto. Essi sono però 
molto costosi; inoltre, limiti legati al loro impatto ambientale e alla sicurezza dell’impianto 
vanno tenuti in considerazione. Pertanto, al fine di evitare il loro utilizzo, è stato 
sviluppato un processo innovativo di purificazione basato sulla tecnologia della 
filtrazione tangenziale. Il processo prevede due passaggi di ultrafiltrazione ed è 
costituito dalle seguenti operazioni: centrifugazione per allontanare le cellule; 
purificazione a 30 kDa per ritenere impurezze ad alto peso; precipitazione in solfato 
d’ammonio per concentrare il prodotto e ulteriore concentrazione e diafiltrazione a 3 kDa 
per l’allontanamento di sali ed altri metaboliti a basso peso. Questa procedura è stata 
comparata con processi di purificazione basati sull’utilizzo di solventi organici 
(butanolo/acetone e cloroformio/metanolo). Una resa di peptide del 75 % è stata 
ottenuta nella procedura con membrane, superiore a quelle dei due trattamenti con 
solventi organici (25 e 50 %, rispettivamente). Anche la purezza da altri contaminanti 
proteici è stata migliore con fattore di purificazione maggiore di 57, corrispondente ad 
un’attività specifica di circa 8700 unità di batterocina per mg di proteine. La validità delle 
procedura è stata valutata anche su un volume superiore (15 L). Utilizzando i medesimi 
parametri di processo (pressione transmembrana, flusso tangenziale, configurazione 
delle membrane) sono state ottenute simili prestazioni nei processi di membrana. 
Il prodotto purificato è stato utilizzato per caratterizzare lo spettro di attività antimicrobica 
di E. casseliflavus CGA1 utilizzando come ceppi test sia batteri starter che patogeni. 
Oltre che verso L. monocytogenes, l’enterocina si è rivelata attiva anche verso colture 
starter di prodotti caseari, quali Lactobacillus bulgaricus  DSM 21081 e Lactobacillus 
casei DSM 20011. Nessuna attività è stata invece osservata verso Lactobacillus 
plantarum DSM 12028, tipico starter delle carni isolato dai salami. Ovviamente l’assenza 
di attività verso microrganismi benefici dell’alimento è critica per una effettiva 
applicazione del prodotto come biopreservante. I dati ottenuti sembrano individuare 
nell’enterocina prodotta da E. casseliflavus CGA1 un promettente candidato come 
additivo naturale delle carni. Ulteriori prove devono essere effettuate per saggiare 
l’effettiva abilità del peptide di inibire microrganismi indesiderati nell’alimento.  
Lo stesso spettro di attività è stato utilizzato per valutare le potenzialità inibitorie di due 
lattobacilli, Lactobacillus plantarum DSM 12028 e Lactobacillus crispatus L1. Il primo è 
uno starter delle carni, il secondo è un isolato vaginale con potenzialità probiotiche. 
Entrambi i microrganismi si sono rivelati capaci di inibire patogeni come Staphilococcus 
aureus e ceppi di Escherichia coli, in questo caso grazie all’azione combinata con 
EDTA, che rende accessibile alle batteriocine la membrana cellulare di batteri Gram 
negativi. Vista l’attività verso batteri patogeni, la produzione di batteriocine da questi due 
microrganismi è stata studiata più approfonditamente. Sono stati quindi effettuati 
esperimenti in beuta finalizzati a valutare l’effetto che concentrazioni diverse (1, 5 e 10 
g·L-1) di bactocasitone, fonte complessa di azoto comunemente utilizzata per coltivare 
batteri lattici, hanno sulla produzione di batteriocina. Nel caso di L. plantarum DSM 
12028, non vi è effetto tra 10 e 5 g·L-1. La produzione osservata di batteriocina è 40 
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BU·mL-1 in entrambi i terreni. L’effetto della concentrazione si è fatto sentire invece per 
L. crispatus L1: l’attività è dimezzata al diminuire della concentrazione di bactocasitone 
da 10 a 5 g·L-1. Nessuna produzione di batteriocina è stata invece osservata a 
concentrazione 1 g·L-1 di nutriente complesso, indicando come una alta quantità di fonte 
d’azoto sia essenziale per osservare una produzione basale di batteriocina. 
Per entrambi i ceppi, sono stati inoltre effettuate crescite in fermentatore in modalità 
batch. L’ambiente di reazione più controllato ha permesso di migliorare la produzione di 
peptide. In particolare, nel caso di L. plantarum DSM 12028 è stato osservato un 
miglioramento di tre volte dell’attività, con una produzione specifica di 14.4 BU·mL-1·OD-
1, superiore a quella ottenuta in beuta. Per L. crispatus L1, la produzione specifica 
misurata in fermentatore (circa 13 BU·mL-1·OD-1) è stata inferiore a quella ottenuta in 
beuta (15.3 BU·mL-1·OD-1), nonostante il miglioramento di due volte dell’attività. 
Anche in questo caso il ricorso a strategie fermentative ad alta densità cellulare 
permetterà di migliorare ulteriormente la produzione di queste batteriocine di interesse 
applicativo.      
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1. INTRODUCTION 
  
1.1 Food safety and preservation 
 
Since the age of Louis Pasteur and Robert Koch, there has been scientific recognition of 
an essential need to control detrimental microorganisms in our environment. The 
discovery of penicillin by Alexander Fleming in 1929 opened the door for use of 
therapeutic antibiotics by the medical and veterinary communities to fight specific 
disease-causing organisms. Although therapeutic antibiotics are prohibited for use in 
foods, the utilization of antagonistic additives with preservative or antimicrobial 
properties has become a trademark approach (and a modern challenge) in food safety 
and preservation.  
By definition, food preservation involves action taken to maintain foods with the desired 
properties or nature as long as possible (Raman S., 1999). It lies at the heart of food 
science and technology, and it is a main purpose of food processing. 
Looking back at recent progress in food biotechnology, it is a fact that the problem of 
food security still remains to be solved. In spite of the introduction of modern 
technologies and safety concepts (e.g. HACCP), the reported number of food-borne 
illnesses and intoxications is still increasing. Estimates from the Centers for Disease 
Control and Prevention in the United States suggest that there are 76 million cases of 
food-borne illness the US each year, which results in about 5000 deaths (Cleveland et 
al., 2001). The US cost of food-borne illness associated with Campylobacter jejuni, 
Clostridium perfringens, Listeria monocytogenes, Salmonella, Staphylococcus aureus 
and Toxoplasma gondii is between 6.5 and 34.9 $ billion (Buzby and Roberts, 1997). 
Recent outbreaks of emerging pathogens such as L. monocytogenes have prompted the 
food industry to question the adequacy of current methods of food preservation.  
Approaches of food preservation were initially based on the utilization of chemically 
synthetized additives. On the other hand, consumers have been consistently concerned 
about possible adverse health effects from the presence of chemical additives in their 
foods. As a result, consumers are drawn to natural and “fresher” foods with no chemical 
preservatives added. This perception, coupled with the increasing demand for minimally 
processed foods with long shelfllife and convenience, has stimulated research interest in 
finding natural but effective preservatives. Recently, approaches of biological 
preservation of foods have become a well established weapon in the food preservation 
arsenal. The primary aim of these applications is of course the reduction of health risks 
without changing the qualities (e.g. sensory qualities) of the product. 
 
1.2 Biological preservation of foods 
 
Biological preservation implies a novel scientifically.based approach to improve the 
microbiological safety of foods. By definition, this concept refers to the use of 
antagonistic microorganisms (protective cultures) or their metabolic products 
(biopreservatives) to inhibit or destroy undesired microorganisms in foods  to enhance 
food safety and prolong shelflife (Schillinger et al., 1996). A distinction is sometimes 
made between starter cultures and protective cultures; actually, it may be the same 
culture applied for different purposes under different conditions (Holzapfel et al., 1995). 
For a starter culture metabolic activity (e.g. acid production) has technological 
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importance whilst antimicrobial action may constitute a secondary effect; for a protective 
culture the functional objectives are inverse. 
Lactic acid bacteria (LAB) have been involved in the fermentation and processing of a 
range of milk, meat, cereal and vegetable foods (McKay and Baldwin, 1990). In these 
foods, they are able to produce a large variety of compounds that contribute to their 
flavour, color, texture and consistency. Owing to their typical association with food 
fermentation and also their long tradition as food-grade bacteria, LAB also traditionally 
provide the major preservative effects in food processing which mankind has practiced 
for thousands of years. 
LAB are a physiologically diverse group of organisms, which can be generally described 
as Gram-positve, nonsporing cocci or rods with lactic acid as the major product of 
carbohydrate fermentation. Traditionally, LAB comprise the four genera Lactobacillus, 
Leuconostoc, Pediococcus and Streptococcus. However, several new genera have 
been suggested for inclusion in the group of LAB due to a recent taxonomic revision 
(Axelsson S., 1998). The genus Streptococcus has been reorganized into Enterococcus, 
Lactococcus, Streptococcus and Vagococcus.   
Modern approaches of biological preservation of foods that use LAB exploit the 
antimicrobial potential of protective cultures, food-grade enzymes and bacteriocins. As 
this research project is focused on the production and characterization of bacteriocins 
produced by some LAB strains, their use in food preservation will be discussed apart 
and more extensively.  
 
1.2.1 Protective cultures 
  
Protective cultures should in first place be considered as additional safety factor, with 
the potential of improving the microbiological safety of food. Their implementation should 
support good manufacturing practices (GMP), thereby reducing risks of growth and 
survival of pathogens and spoilage organisms. In addition under abuse conditions of 
temperature, handling, etc., their metabolic activities (e.g. acid or gas production) may 
serve as an indicator of microbial risk.  
The LAB, generally considered as “food-grade” organisms, offer special promise for 
selection and implementation as protective cultures. Involved in numerous food 
fermentations known to man for millennia, it is assumed that most representatives of this 
group do not pose any health risk, and some are designated as GRAS (Generally 
Regarded As Safe) organisms. Reports on the involvement of LAB in human infections 
(Aguirre and Collins, 1993) indicate that some species may act as opportunistic 
pathogens in rare cases. However, there is no indication of a health risk of LAB 
associated with food fermentations. On the other hand, in a number of product groups, 
especially dairy products, the use of protective cultures may also contribute to the health 
benefits of a product. Such probiotic cultures are considered to provide substantial 
health benefits to man by means of stabilising or normalising the gastro-intestinal tract 
(Holzapfel et al., 1995). Some LAB strains are even associated with anticarcinogenic 
action and tumour control (Adachi S., 1992). These health traits may serve as important 
advantage for selection and development of protective cultures. 
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1.2.1.1 Mechanisms of antagonism of LAB protective cultures 
 
Antagonism refers to the inhibition of other (e.g. undesired or pathogenic) 
microrganisms, caused by competition for nutrients and by the production of 
antimicrobial metabolites.  
The production of one or more antimicrobially active metabolites is part of the complex 
mechanism by which a culture becomes established in the presence of other competing 
organisms. Understanding these mechanisms provides a valuable key towards 
biological approaches in food preservation. In Table 1 the antimicrobial properties of a 
number of metabolites from LAB are summarised. They include small metabolites, 
enzymes and bacteriocins. These last two categories will be discussed below in detail.   
Depending on the product and processing, one or more of these metabolites may 
constitute a basis for the selection of a protective culture. 
 
Organic acids. Lactic acid, the primary fermentation product of LAB, may reduce the pH 
to a level where pathogenic (e.g. salmonellae and Listeria spp.) and toxinogenic bacteria 
(Staphylococcus aureus, Bacillus cereus, Clostridium botulinum) will either be inhibited 
or destroyed. Moreover, the undissociated form will diffuse into the bacterial cell, thereby 
reducing the intracellular pH, thus slowing down metabolic activities. The rapid reduction 
of pH below 5.3 during raw sausage fermentation is sufficient to inhibit growth of 
salmonellae and Staphylococcus aureus (Schillinger and Lücke, 1988). 
Due to its higher dissociation constant, acetic acid (pKa 4.75) shows stronger inhibition 
than lactic acid (pKa 3.1) at a given molar concentration and pH. Produced by 
heterofermentative LAB (Leuconostoc spp. and some lactobacilli) in equimolar amounts 
with lactic acid from hexoses sugars, acetic acid may constitute a vital factor for the 
establishment of the initial LAB population during several “spontaneous” fermentations 
(Buckenhüskes et al., 1990). 
In a number of fermented dairy products, the benzoic acid concentration significantly 
exceeds the naturally expected value (Daeschel M.A., 1989). This constitutes an 
additional preservation factors in these dairy foods. 
 
Hydrogen peroxide. Hydrogen peroxide is produced by a number of LAB in the presence 
of oxygen together with lactate, pyruvate and NADH (Kandler O., 1983). Undesired 
bacteria such as Pseudomonas spp. and Staphylococcus aureus are 2 to 10 times more 
sensitive to hydrogen peroxide than most LAB. In addition, this molecule may activate 
the lactoperoxidase system which is endogenous to fresh milk with the formation of 
hypothiocyanite and other antimicrobial products (Reiter and Härnulv, 1984). 
As for other metabolic products, the tolerable amount of hydrogen peroxide is 
dependent on the product type, and may be detrimental to its qualities. 
 
Low molecular weight metabolites. A number of primary metabolites of low molecular 
weight is known for their relatively potent antimicrobial activities.  
Diacetyl is produced by some Lactococcus, Leuconostoc and Pediococcus spp. (e.g. 
during degradation of citric acid). Due to its intensive aroma, diacetyl has little direct 
potential for the preservation of food.  
Carbon dioxide produced by heterofermenters from hexoses is directly toxic to aerobic 
putrefactive bacteria but may promote the growth of others. 
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Product 
 
 
Main target organisms 
 
Organic acids 
 
¾ lactic acid 
 
¾ acetic acid 
 
 
 
Putrefactive and Gram-negative bacteria, some fungi 
 
Putrefactive bacteria, clostridia, some yeasts and fungi 
 
 
Hydrogen peroxide 
 
 
Pathogens and spoilage organisms, especially in protein-
rich foods 
 
 
Enzymes 
 
¾ lactoperoxidase with H2O2 
 
¾ lysozyme 
 
 
 
Pathogens and spoilage bacteria (dairy products) 
 
Undesired Gram-positive bacteria 
 
Low molecular weight metabolites 
 
¾ reuterin 
 
¾ diacetyl 
 
¾ fatty acids 
 
 
 
 
Wide spectrum of bacteria, moulds and yeasts 
 
Gram-negative bacteria 
 
Different bacteria 
 
Bacteriocins 
 
¾ nisin 
 
 
¾ others 
 
 
 
 
Some LAB and Gram-positive bacteria notably endospore-
formers 
 
Gram-positive bacteria, inhibitory spectrum according to 
producer strain and bacteriocin type 
 
Table 1 
Antimicrobial compounds produced by lactic acid bacteria. 
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Reuterin, or 3-hydroxypropionaldehyde, is produced from glycerol in Lactobacillus 
reuteri. It shows broad-spectrum antimicrobial activity, probably by inhibition of 
ribonucleotide reductase, and has been suggested for biopreservation of fish and meat, 
using L. reuteri (Daeschel M.A., 1989; Lindgren and Dobrogosz, 1990).  
  
1.2.2 Food grade enzymes 
 
The secretion of an antibacterial enzyme, such as lysozyme, may improve the activity 
spectrum of protective cultures, and may render such a strain more suitable for 
application under versatile conditions. 
As for antimicrobial metabolites, a number of enzymes serve in nature to protect a 
biological system against invasion of certain microorganisms. Typical examples are 
lysozyme in egg albumen and lactoperoxidase in milk. Food systems which contain such 
antagonistic enzymes possess an intrinsic stability against microorganisms. On the 
other hand, purified antagonistic enzymes can be used as biopreservatives for foods 
which do not contain such antagonistic products, as for example the addition of 
lysozyme to cheese to prevent late blowing due to Clostridium tyrobutyricum (Bester and 
Lombard, 1990). 
From a regulatory point of view, enzymes are considered as food additives and require 
special approval of “food grade” quality or GRAS status. 
 
Lysozyme, one of the most important of them, can be found in milk and eggs. It is a 
muraminidase that hydrolyses β-1,4 linkages between N-acetylmuramic acid and N-
acetylglucosamine of the peptidoglycan, causing the lysis of bacterial cells. Gram-
negative bacteria possess an outer membrane, which may protect the cell wall against 
the action of lysozyme. After disruption of the outer membrane by chelating membrane-
stabilizing divalent cations with EDTA, also Gram-negative microorganisms become 
susceptible to the action of lysozyme. 
Lysozyme is especially active against the outgrowth of clostridial spores but it shows 
activity against other pathogenic or toxinogenic bacteria such as Bacillus and Listeria. 
Investigations have especially concerned with control of the growth of L. monocytogenes 
(Carminati and Carini, 1989; Bester and Lombard, 1990). Lysozyme can control the 
growth of this microorganism in culture broth systems (Hughey and Johnson, 1987) and 
in real food systems like milk (Carminati and Carini, 1989) and cheese (Bester and 
Lombard, 1990), where it shows a remarkable stability. 
 
Lactoperoxidase is an enzyme naturally occurring in milk. It represses the growth of 
Staphylococcus aureus and Listeria monocytogenes if activated in milk. It can be 
activated by thiocyanate ions and hydrogen peroxide. In the presence of both substrates 
lactoperoxidase oxidizes thiocyanate to hypothiocyanite. This is a strong oxidizing agent 
which in turn can oxidize essential sulfhydryl groups in bacterial proteins but is harmless 
to host cells (Kamau et al., 1990). Thiocyanate ions are present in milk and hydrogen 
peroxide can be produced by accompanying LAB.  
 
Glucose oxidase oxidizes glucose to glucuronic acid in the presence of oxygen. In 
addition hydrogen peroxide is produced. This enzyme is already used in food industry to 
remove oxygen from various packaged or canned food products. It is in addition able to 
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repress the growth of certain Gram-positive as well as Gram-negative microorganisms. 
This inhibitory effect depends on the concentration of the enzyme in the medium and on 
glucose as substrate. Higher inhibitory activity can be observed at higher enzyme 
concentrations (Tiina and Sandholm, 1989). These experiments were performed in broth 
culture. On the other hand Jeong and co-workers (1992) demonstrated that glucose 
oxidase was not useful to inhibit the growth of Pseudomonas or Salmonella spp. on 
chicken breast skin. Glucose oxidase might be more active in liquid food systems. 
 
Lactoferrin is an iron binding protein in milk, with activity towards Bacillus subtilis, B. 
stearothermophilus and Escherichia coli. These microorganisms are apparently inhibited 
due to the iron chelating capacity of the enzyme. Lactoferricin B is a proteolytic cleavage 
product of lactoferrin. It is a peptide of 25 amino acids and has much higher antagonistic 
activity than lactoferrin towards a lot of microorganisms, notably Salmonella enteritidis, 
Campylobacter jejuni, Staphylococcus aureus, Listeria monocytogenes and Clostridium 
perfrigens (Bellamy et al., 1992). 
 
1.3 Bacteriocins 
 
As mentioned above, lactic acid bacteria are a source of antimicrobial peptides called 
bacteriocins, which have been examined for applications in microbial food safety. 
However, the bacteriocins were first characterized in Gram-negative bacteria. First 
discovered by Gratia in 1925, “principe V” was produced by one strain of Escherichia 
coli against another culture of E. coli. The term “colicine” was coined by Gratia and 
Fredericq in 1946; “bacteriocin” was subsequently used (1953) as a general term for 
highly specific antibacterial proteins. The term colicin now implies a bacteriocidal protein 
produced by varieties of E. coli and closely related Enterobacteriaceae (Konisky J., 
1982). 
Bacteriocins (as colicins) were originally defined as bacteriocidal proteins characterized 
by lethal biosynthesis, a very narrow range of activity, and adsorption to specific cell 
envelope receptors . Later, the recognized association of bacteriocin biosynthesis with 
plasmids was added to the description. The definition has since been modified to 
incorporate the properties of bacteriocins produced by Gram-positive bacteria (Tagg et 
al., 1976), notably LAB able to produce peptides with potential as effective natural food 
preservatives. Bacteriocins from Gram-positive bacteria commonly do not possess a 
specific receptor for adsorption, are most frequently of lower molecular weight than 
colicins, have a broader range of target bacteria with different modes of release and cell 
transport, and possess leader sequences cleaved during maturation (Riley M.A., 1998). 
Currently, bacteriocins produced by LAB are defined as peptides or small proteins, 
ribosomally synthetized and extracellularly released, that display inhibitory activity 
towards Gram-positive bacteria, in particular closely related strains (Ennahar et al., 
2000). Since their inhibitory spectrum often encompasses food pathogens and spoilers, 
they are natural additives for foods in the frame of an innovative food preservation (Jack 
et al., 1995). Although nisin is currently the only bacteriocin approved for use in many 
countries, a lot of bacteriocins produced by members of LAB have potential application 
in food products. 
Bacteriocins are often confused in the literature with antibiotics (Hansen J.N., 1993). 
This would limit their use in food applications from a legal standpoint. So, it is critical to 
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make the distinction between bacteriocins and antibiotics. Their main differences are 
summarized in Table 2. Recognizing that bacteriocins are different from antibiotics, 
Hurst A. (1981), in his review, proposed the term “biological food preservatives” since 
bacteriocins, unlike antibiotics, are not used for medicinal purposes. 
 
1.3.1 Classification of bacteriocins 
 
Most of the bacteriocins from LAB are cationic, hydrophobic, or amphiphilic molecules 
composed of 20 to 60 amino acid residues (Nes and Holo, 2000). They are commonly 
classified into 3 groups that also include bacteriocins from other Gram-positive bacteria 
(Chen and Hoover, 2003). Examples of bacteriocins from these 3 classes are 
summarized in Table 3. 
 
Class I. Class I is being further subdivided into class Ia and class Ib. In general, Class I 
peptides tipically have from 19 to more than 50 amino acids. Class I bacteriocins are 
characterized by their unusual amino acids, such as lanthionine, methyl-lanthionine, 
dehydrobutirine and dehydroalanine, so they are also called lantibiotics (from 
lanthionine-containing antibiotic). Class Ia bacteriocins, which include nisin, consist of 
cationic and hydrophobic peptides that form pores in target membranes and have a 
flexible structure compared to the more rigid class Ib. Class Ib bacteriocins, which are 
globular peptides, have no net charge or a net negative charge; antimicrobic activity is 
related to the inhibition of specific enzymes (Altena et al., 2000).  
 
Class II. Small (<10 kDa), heat-stable, non-lanthionine-containing peptides are 
contained in class II. The largest group of bacteriocins in this classification system, 
these peptides are divided into 3 subgroups. Class IIa includes pediocin-like peptides 
having an N-terminal consensus sequence -Tyr-Gly-Asn-Gly-Val-Xaa-Cys. This 
subgroup has attracted much of the attention due to their anti-Listeria activity (Ennahar 
et al., 2000). Class IIb contains molecules requiring two different peptides for activity, 
and class IIc contains the remaining peptides of the class, including sec-dependent 
secreted bacteriocins (Nes et al., 2000). 
 
Class III. The class III bacteriocins are not well characterized. This group includes large 
(>30 kDa), heat-labile proteins that are of lesser interest to food scientists.  
A fourth class consisting of complex bacteriocins that require carbohydrate or lipid 
moieties for activity has also been suggested by Klaenhammer T.R. (1993); however, 
bacteriocins in this class have not been characterized adequately at the biochemical 
level to the extent that the definition of this class requires additional descriptive 
information (McAuliffe et al., 2001). 
 
1.3.1.1 Properties and activity spectra of class I and class IIa Bacteriocins 
 
Class I and class IIa bacteriocins are usually very stable at acidic pH. For example, 
Rodriguez and co-workers (2002) found that pediocin PA-1 was perfectly stable after 21 
days of storage at 15 °C at pH 4 to 6; however, half of the activity was lost at pH 7.  
In addition, bacteriocins from these two classes are heat stable at acidic pH. As pH   
increases, their heat stability decreases. Jack and co-workers (1996) found that heating  
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Characteristic 
 
Bacteriocins 
 
Antibiotics 
 
Application 
 
Food 
 
Clinical 
 
Synthesis 
 
Ribosomal (primary metabolites) 
 
Secondary metabolites 
 
Activity 
 
Narrow spectrum 
 
Varying spectrum 
 
Host cell immunity 
 
Yes 
 
No 
 
Mechanism of target cell 
resistance or tolerance 
 
Usually adaptation affecting cell 
membrane composition 
 
Usually a genetically 
transferable determinant 
affecting different sites 
depending the mode of 
action 
 
Interaction requirements 
 
Sometimes docking molecules 
 
Specific target 
 
Mode of action 
 
Mostly pore formation, but in few cases 
also cell wall byosinthesis 
 
Cell membrane or 
intracellular targets 
 
Toxicity/side effects 
 
None known (rapidly digested by 
proteases in the human digestive tract) 
 
Yes 
 
Group  
 
Bacteriocins 
 
Producer 
 
Class Ia lantibiotics 
 
Nisin, lacticin 481 
Lactocin S 
Epidermin 
 
Lactococcus lactis 
Lactobacillus sake 
Staphylococcus epidermidis 
 
Class Ib lantibiotics 
 
Mersacidin 
Cinnamycin 
Ancoverin 
 
Bacillus subtilis 
Streptomyces cinnamoneus 
Streptomyces ssp. 
 
Class IIa 
 
Pediocin PA-1/AcH 
Sakacin A, sakacin P 
Mesentericin Y105 
Enterocin A 
 
Pediococcus acidilactici 
Lactobacillus sake 
Leuconostoc mesenteroides 
Enterococcus faecium 
 
Class IIb 
 
Lactococcin G, lactococcin M 
Plantaricin A, plantaricin S 
 
Lactococcus lactis 
Lactobacillus plantarum 
 
Class IIc 
 
Acidocin 
Enterocin P, enterocin B 
 
Lactobacillus acidophilus 
Enterococcus faecium 
 
Class III 
 
Helveticin J, helveticin V-1829 
 
Lactobacillus helveticus 
Table 3 
Examples of bacteriocins. 
Table 2 
Bacteriocins vs. antibiotics. 
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of piscicolin 126 for 120 min at pH 2 and 3 did not affect its bactericidal activity, while 
heating for 15 min at pH 4 or 5 reduced its activity by 50%.  
In general, class I and class IIa bacteriocins are usually sensitive to proteolytic enzymes, 
such as trypsin, due to their proteinaceous nature. 
Differences between two classes can be found in the activity spectra. 
Most of the class I bacteriocins have a fairly broad inhibitory spectrum. They not only 
inhibit closely related bacteria, such as species from the genera Enterococcus, 
Lactobacillus, Lactococcus, Leuconostoc, Pediococcus, and Streptococcus, but also 
inhibit many less closely related Gram-positive bacteria, such as L. monocytogenes, 
Staphylococcus aureus, Bacillus cereus, and Clostridium botulinum (Chen and Hoover, 
2003). Interestingly, several bacteriocins in this class, such as nisin and thermophilin 13, 
also prevent outgrowth of spores of B. cereus and C. botulinum.  
Compared to class I bacteriocins, most class IIa bacteriocins have comparatively narrow 
activity spectra and only inhibit closely related Gram-positive bacteria. In general, 
members of the genera Enterococcus, Lactobacillus, Pediococcus are sensitive to class 
IIa bacteriocins, and members of the genus Lactococcus are resistant. Some class IIa 
bacteriocins, such as pediocin PA-1, have fairly broad inhibitory spectra and can inhibit 
some less closely related gram-positive bacteria, such as S. aureus and vegetative cells 
of Clostridium spp. and Bacillus spp. 
Interestingly, class IIa bacteriocins are generally active against Listeria. Eijsink and co-
workers (1998) found that 9 strains of Listeria tested, including L. monocytogenes, 
Listeria innocua, and Listeria ivanovii, were very sensitive to four class IIa bacteriocins 
(namely pediocin PA-1, enterocin A, sakacin P, and curvacin A).  
It might seem that bacteriocins with broader activity spectra would always be preferable 
for use in food preservation, but under certain circumstances the ones with narrower 
inhibitory spectra may prove more desirable. For example, sakacin P, which has limited 
activity against LAB but is nearly as effective as pediocin PA-1 against Listeria, might 
find application in LAB fermentation products that are prone to contamination by L. 
monocytogenes (Eijsink et al., 1998). 
 
1.3.2 Genetics, biosynthesis and mode of action 
 
1.3.2.1 Organization of gene clusters and biosynthetic pathway 
 
The genes encoding bacteriocin production and immunity are usually organized in 
operon clusters. Bacteriocin gene clusters can be located on the chromosome, as in the 
case of mersacidin (Altena et al., 2000), on plasmids, as for sakacin A (Axelsson and 
Holck, 1995), or on transposons, as in the case of nisin (McAuliffe et al., 2001).  
Typically, bacteriocin-producing LAB possess genes coding for the structural peptide, 
proteins that aid in processing to the active form, proteins deputated to the transport of 
the bacteriocin across the membrane, regulatory proteins, and proteins that confer 
immunity to the host producer. 
Operons containing the genes for lantibiotic production are well studied, and 
homologous genes are found among the many of the sequenced lantibiotic operons, as 
reviewed by Siezen and co-workers (1996). Most characterized lantibiotic operons 
belong to class Ia.  
The genetic regulation of many Class II bacteriocins has been also studied (Venema et 
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al., 1995; Diep et al., 1996) and shares many similarities with lantibiotics operons. 
Though bacteriocins are ribosomally synthesized, the resulting product, a biologically 
inactive prepeptide carrying an N-terminal leader peptide that is attached to the C-
terminal propeptide, must be modified before becoming active. Genes coding for the 
enzymes that facilitate the modifications are usually in close proximity to the structural 
gene.  
For lantibiotics, extensive post-translational modifications include the formation of 
several unusual amino acids. It has been proposed that serine and threonine are 
modified to dehydroalanine and dehydrobutyrine, respectively, and that these amino 
acids serve as precursors to lanthionine and methyl-lanthionine, the formation of which 
occurs upon the addition of cysteine thiol groups (Kupke and Gotz, 1996). 
The biosynthetic pathway of lantibiotics follows a general scheme: formation of 
prepeptide, modification reactions, proteolytic cleavage of the leader peptide, and the 
translocation of the modified prepeptide or mature propeptide across the cytoplasmic 
membrane, through a dedicated ABC-tranporter system (McAuliffe et al., 2001). 
Cleavage of the leader peptide may take place prior to, during, or after export from the 
cell.  
Class II bacteriocins are synthetized as a prepeptide containing a conserved N-terminal 
leader and a characteristic double-glycine proteolytic processing site, with the exception 
of class IIc bacteriocins, which are produced with a typical N-terminal signal sequence of 
the sec-type and processed and secreted through the general secretory pathway. Unlike 
the lantibiotics, class II bacteriocins do not undergo extensive post-translational 
modification. 
Following the formation of prepeptide, the prepeptide is processed to remove the leader 
peptide concomitant with export from the cell through a dedicated ABC-transporter and 
its accessory protein (Ennahar et al., 2000). 
 
1.3.2.2 Mode of action 
 
Bacteriocins, particularly lantibiotics, inhibit target cells by forming pores in the 
membrane, depleting the transmembrane potential and/or the pH gradient, resulting in 
the leakage of cellular materials (Okereke and Montville, 1992). 
Bacteriocins are positively charged molecules with hydrophobic patches. Electrostatic 
interactions with negatively charged phosphate groups on target cell membranes are 
thought to contribute to the initial binding with the target membrane (Chen et al., 1997). 
The association of hydrophobic patches of bacteriocins with the hydrophobic membrane 
has also been modeled using computer simulation to predict the most favorable 
interaction (Lins et al., 1999). It is likely that the hydrophobic portion inserts into the 
membrane, forming pores 
For other cationic non-lantibiotics peptides, the peptide concentration required to cause 
membrane depolarization does not always correspond with the minimal inhibitory 
concentration (MIC) and does not necessarily cause cell death (Friedrich et al., 2000). 
One may speculate that entry into the cell may be required to access targets such as 
DNA, RNA, enzymes and other sites to kill the target cell. 
There is evidence that one Class II bacteriocin actually inhibits septum formation in 
susceptible bacteria (Martinez et al., 2000). 
Because bacteriocins do not act equally against target species, researchers have 
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examined the affinity of bacteriocins to specific species and strains. The phospholipid 
composition of the target strains and environmental pH influence the MIC values (Chen 
et al., 1997). Differently from pore formation occurring indiscriminately, it appears that 
“docking molecules” on the target cell membrane facilitate the interaction with the 
bacteriocin, thereby increasing the effectiveness of the bacteriocin. This mechanism has 
been clearly demonstrated for nisin and mersacidin, which both use lipid II, a 
peptidoglycan precursor, as a docking molecule (Breukink et al., 1999). Mersacidin 
correspondingly inhibits peptidoglycan synthesis, whereas the primary mode of action of 
nisin is pore formation resulting in leakage of cellular materials. Figure 1 shows the nisin 
mode of action according to this model. Now, it is believed that in some cases cell wall 
biosynthesis may also be a target for nisin action. 
 
1.3.2.3 Bacteriocin immunity 
 
The immunity of the bacteriocin-synthesizing cell to its product is a phenomenon that 
distinguishes bacteriocins from antibiotics. Genes coding for so-called “immunity 
proteins” are in close genetic proximity to other bacteriocin structural and processing 
genes (Siegers and Entian, 1995). It is common for the structural bacteriocin gene and 
the immunity gene to be located on the same operon and often next to each other (Nes 
et al., 1996). In the class II bacteriocins, immunity protein is usually a basic protein 
between 50 and 150 amino acid residues long that is loosely associated with the 
membrane. 
Despite the protection mechanism has not been unravelled yet, it is believed that 
immunity proteins bind to the membrane preventing interaction and/or pore formation 
caused by bacteriocins (Chen and Hoover, 2003). 
 
1.3.3 Resistance mechanisms 
 
The presence of an antibacterial substance in a given environment will eventually select 
for varieties of bacteria resistant to the antagonistic component. Cells already exhibit 
resistance to several antibiotics and the transfer of resistance between organisms has 
been documented.  
Bacteriocin-resistant mutants also occur. Gravesen and co-workers (2002) examined 
the responses of a number of strains of L. monocytogenes to pediocin PA-1 and nisin, 
and found a wide range of resistances to the two bacteriocins occurring naturally. The 
influence of environmental stress (reduced pH, low temperature, and the presence of 
sodium chloride) appeared bacteriocin-specific; in particular, these stresses did not 
influence the frequency of resistance to pediocin PA-1, but the frequency of nisin 
resistance was significantly reduced. Interestingly, the stability of the phenotype of nisin 
resistance varied substantially, while resistance to the pediocin was stable with ongoing 
growth of L. monocytogenes.  
The genes for synthesis of pediocin PA-1 were transferred into nisin-producing L. lactis 
FI5876 by Horn and co-workers (1999). As a result, both pediocin PA-1 and nisin A were 
synthesized concurrently in this strain of Lactococcus. Production levels of pediocin PA-
1 were at the same levels as found in the original producer of the pediocin, P. acidilactici 
347. Since pediocin PA-1 and nisin A are unrelated bacteriocins, use of L. lactis FI5876 
as a starter culture in fermented dairy products should prevent the emergence of any  
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Figure 1 
Proposed mode of action for nisin in according to “docking molecules” model 
(Breukink et al., 1999). 
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bacteriocin-resistant isolates of L. monocytogenes because the frequency for 
emergence of a strain resistant to both peptides should be low. 
Although bacteriocins are not antibiotics, another question regards the resistance to 
antibiotics caused by exposure to bacteriocins. Since antibiotics and nisin have different 
modes of action, it has been shown that exposure to nisin has no effect on the 
frequency of resistance of L. monocytogenes  to ampicillin and chloramphenicol 
(Tchikindas et al., 2000). In another study, following a different approach several multi-
drug resistant bacteria were subjected to up to 400 IU/ml nisin, and these organisms 
remained sensitive to nisin (Severina et al., 1998).  
Though bacteria exhibiting nisin resistance do not show cross-resistance with 
antibiotics, it is still important to understand the mechanism of resistance so that it can 
be avoided. Antibiotic resistance is usually associated with a genetic determinant, 
facilitating the transfer of resistance between cells. Unlike most antibiotic resistance, 
bacteriocin resistance results from a physiological change in the target cell membrane. 
For L. monocytogenes, a more rigid membrane, usually having a lower C15:C17 ratio 
results in increased tolerance to nisin (Crandall and Montville, 1998). Ming and 
Daeschel (1993) also found that nisin resistant L. monocytogenes have reduced 
amounts of phosphatidylglycerol, diphosphatidylglycerol and bisphosphatidylglycerol 
phosphate. Though most research show that a change in cell membrane composition 
accounts for resistance, some mutants produce an enzyme, nisinase, which degrades 
nisin (Jarvis B., 1967).   
 
1.3.4 Determination of bacteriocin activity 
 
Among the many methods described to assay antimicrobial activity, the methods 
reported below have been frequently used to determinate bacteriocin activity (Parente et 
al., 1995). 
 
Agar diffusion assay. The agar diffusion method has long been used for testing 
antimicrobial activity, and it was first used by Fleming in 1924 (Piddock L.J., 1990). It 
includes agar well diffusion assay and disc assay. In this test, the bacteriocin solution is 
delivered to an agar plate (inoculated with a test microrganism) in a well or on a paper 
disc. The compound diffuses into agar resulting in a concentration gradient that is 
inversely proportional to the distance from the disc or well. The size of the inhibition 
zone around the disc or well is a measure of the degree of inhibition. The results of the 
test are generally qualitative. The method requires that the indicator organisms must 
grow rapidly, uniformly, and aerobically. 
Several modified procedures based on the agar diffusion method have also been used 
for testing antimicrobial activity of LAB. These procedures include the agar spot test, 
deferred antagonism assay, and “spot on lawn” assay. 
 
Critical dilution assay. Dilution methods are used as quantitative methods (Parente et al. 
1995). The results are expressed as bacteriocin activity per mL (BU/mL), which is the 
lowest concentration of bacteriocin that prevents growth of a microorganism after a 
specific incubation period. In this test, the bacteriocin solution is serially diluted and each 
single concentration added to a plate inoculated with test organisms and incubated. The 
critical dilution is defined as the lowest concentration at which an inhibition halo occurs.  
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Turbidimetric assay. A turbidimetric assay based on automated systems determines the 
effect of an antimicrobial compound on the growth or death kinetics of a microorganism. 
Since the bacterial growth is monitored by measuring the turbidity of the broth medium, 
the method demands the instrument to be highly sensitive.  
Skyttä and Mattila-Sandholm (1991) described a quantitative method based on 
automated turbidimetry for assaying antimicrobial activity, which was expressed as area 
reduction percentage values measured under the growth curve. The method has been 
used to test the antimicrobial activity of bacteriocins produced by Lactobacillus 
plantarum (Niku-Paavola et al., 1999). 
 
1.4 Food applications of bacteriocins 
 
Three approaches are commonly used in the application of bacteriocins for biological 
preservation of food (Chen and Hoover, 2003): 
4) Inoculation of food with LAB (protective culture) that produce bacteriocin 
(production in situ). In this case, the ability of the LAB to grow and produce 
bacteriocin  in the products is crucial for its successful use. 
5) Addition of purified or semi-purified bacteriocins as food preservatives. 
6) Use of a product previously fermented with a bacteriocin-producing strain as an 
ingredient in food processing. 
Table 4 reports patented applications of these approaches. Although the number and 
variety of these applications is largely increasing, nisin remains the only bacteriocin 
whose application is approved for effective use in most countries. The use of pediocin 
PA-1 for food biopreservation has been commercially exploited and is covered by 
several U.S. and European patents. Fermentate containing pediocin PA-1, AltaTM, is 
commercially available and used as a food preservative to increase shelflife and inhibit 
the growth of bacteria, especially L. monocytogenes in ready-to-eat meats (Rodriguez et 
al., 2002). Lacticin 3147, which is active over a wider pH range than nisin, is expected to 
find applications in non-acid foods (Ross et al., 1999). 
 
1.4.1 Biopreservation of meat products 
 
Listeria monocytogenes is a Gram-positive, non-sporeforming facultatively anaerobic 
rod widely distributed in the natural environment. It can grow over a pH range of 4.1 to 
9.6 and a temperature range of 0 to 45 °C. The ubiquitous nature of L. monocytogenes, 
its hardness and ability to grow at refrigeration temperatures and anaerobic conditions 
make it a threat to the safety of foods. It is regarded as a major food safety problem 
because it can cause serious illnesses and death (Ryser and Marth, 1999). Many 
studies have been carried out to control L. monocytogenes in meat products since it is 
common within slaughterhouse and meat-packing environments and has been isolated 
from raw meat, and cooked and ready-to-eat meat products (Ryser and Marth, 1999). 
Pawar and co-workers (2000) demonstrated that nisin, alone at concentrations of 400 
and 800 IU·g-1, significantly inhibited the growth of L. monocytogenes in minced raw 
buffalo meat. Addition of 2% sodium chloride in combination with nisin was found to 
increase the efficacy of inhibition. 
Murray and Richard (1997) evaluated the antilisterial activity of nisin A and pediocin AcH 
in decontamination of artificially contaminated pieces of raw pork. Nisin A was 
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Authors 
 
US Patent 
 
Patent title 
 
Description 
 
Vandenbergh 
et al.  
 
5,817,362 
(06.10.98) 
 
 
Method for inhibiting bacteria 
using a novel lactococcal 
bacteriocin  
 
A method for inhibiting Gram-
positive bacteria in foods by usng a 
novel bacteriocin produced by L. 
lactis NRRL-B-18535 
 
Blackburn et 
al. 
 
5,753,614 
(19.05.98) 
 
Nisin compositions for use as 
enhanced, broad range 
bactericides 
 
Combination of nisin, a chelating 
agent and a surfactant to inhibit both 
Gram-positive and Gram-negative 
organisms in meat, eggs, cheese 
and fish 
 
Wilhoit 
 
5,573,801 
(12.11.96) 
 
Surface treatment of 
foodstuffs with antimicrobial 
compositions 
 
Use of Streptococcus-derived or 
Pediococcus-derived bacteriocins in 
combination with a chelating agent 
to protect food against Listeria 
 
Vedamuthu 
 
5,445,835 
(29.08.95) 
 
Method of producing a yogurt 
product containing bacteriocin 
PA-1 
 
A yogurt product with increased 
shelf life containing a bacteriocin 
derived from a P. acidilactici 
 
 
Boudreaux et 
al. 
 
5,219,603 
(15.06.93) 
 
Composition for extending the 
shelf life of processed meats 
 
Use of a bacteriocin from P. 
acidilactici and a propionate salt to 
inhibit bacterial growth and to 
extend shelf life of raw and 
processed meat  
 
Hutkins et al. 
 
 
 
5,186,962 
(16.02.93) 
 
Composition and method for 
inhibiting pathogens and 
spoilage organisms in foods 
 
Use of bacteriocin-producing LAB to 
inhibit growth of food-born 
pathogens 
 
Collison et al. 
 
5,015,487 
(14.05.91) 
 
Use of lanthionines for control 
of post-processing 
contamination in processed 
meats 
 
Inhibiting the contamination of 
processed meat products by 
pathogenic or spoilage 
microorganisms by treating the 
surface of the meat product with a 
lantibiotic 
 
Vandenbergh 
et al. 
 
4,929,445 
(29.05.90) 
 
Method for inhibiting L. 
monocytogenes using a 
bacteriocin 
 
Inhibition of L. monocytogenes by a 
bacteriocin produced by P. 
acidilactici 
 
Gonzalez 
 
4,883,673 
(28.11.89) 
 
 
Method for inhibiting bacterial 
spoilage and resulting 
compositions  
 
Inhibition of food spoilage 
microorganisms in salads and salad 
dressings by a bacteriocin from P. 
acidilactici 
 
Matrozza et 
al. 
 
 
3,790,994 
(13.12.88) 
 
Method for inhibiting 
psychrotrophic bacteria in 
cream or milk based products 
using a Pediococcus 
 
Inhibition of bacterial growth in 
cottage cheese by a bacteriocin-
producing P. pentosaceus cells 
Table 4 
Patented food applications of bacteriocins. 
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considerably more efficient than pediocin AcH, but after 2 days of storage, surviving 
bacteria in meat treated with each bacteriocin resumed growth at a rate similar to that of 
the control. Moreover, nisin was more stable than pediocin AcH. The loss of 
effectiveness, especially of pediocin AcH, was attributed to rapid degradation by meat 
proteases. 
In addition to nisin and pediocin, other LAB bacteriocins have been examined to control 
the growth of Listeria. Examples include Lauková and co-workers (1999), who examined 
the effectiveness of enterocin CCM 4231 in controlling L. monocytogenes contamination 
in dry fermented Hornád salami. Addition of enterocin reduced the counts of L. 
monocytogenes by 1.7 orders of magnitude immediately after addition of the bacteriocin.  
Also, Hugas and co-workers (1998) found that sakacin K, a bacteriocin produced by 
Lactobacillus sake CTC494, inhibited the growth of Listeria  innocua in vacuum- 
packaged samples of poultry breasts and cooked pork, and in modified atmosphere-
packaged samples of raw minced pork.  
Degnan and co-workers (1992) demonstrated the possibility of using protective cultures 
of Pediococcus acidilactici (pediocin AcH producer) to control L. monocytogenes growth 
in vacuum packaged all-beef wieners.  
The primary reasons that nitrite is commonly used in curing meats is to stabilize red 
meat color and inhibit food spoilage and poisoning organisms, such as Clostridium 
botulinum; however, nitrite can react with secondary amines in meats to form 
carcinogenic nitrosamines. This possible adverse health effect has prompted 
researchers to explore the potential of using bacteriocins as an alternative to nitrite. 
Rayman and co-workers (1981) reported that a combination of 3000 IU·g-1 of nisin and 
40 ppm of nitrite almost completely inhibited outgrowth of Clostridium sporogenes 
spores in meat slurries at 37 °C for 56 days; reducing the pH was found to enhance 
nisin activity. 
 
1.4.2 Biopreservation of diary products 
 
L. monocytogenes has been the documented cause of a number of outbreaks 
associated with dairy products, such as pasteurized milk and cheese, and nisin has 
been shown effective against this organism in dairy products. 
Ferreira and Lund (1996) found that following inoculation of a nisin-resistant strain into 
long-life cottage cheese at pH 4.6 to 4.7, the number of L. monocytogenes decreased 
approximately by one order of magnitude for 7 days. Addition of nisin (2000 IU·g-1) to the 
cottage cheese increased the rate of inactivation to approximately 3 orders of magnitude 
in 3 days. 
Davies and co-workers (1997) determined the efficacy of nisin to control L. 
monocytogenes in ricotta-type cheeses over 70 day. Addition of nisin effectively 
inhibited the growth of L. monocytogenes for a period of 8 weeks or more (dependent 
oncheese type).  
Zottola and co-workers (1994) used nisin-containing cheddar cheese that had been 
made with nisin-producing lactococci as an ingredient in pasteurized process cheese or 
cold pack cheese spreads. The shelflife of the nisin-containing pasteurized process 
cheese was significantly greater than that of the control cheese spreads. In cold pack 
cheese spreads, nisin significantly reduced the numbers of L. monocytogenes, S. 
aureus and spores of C. sporogenes.  
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Another problem in cheese production is the Clostridium-associated butyric acid 
fermentation. Nisin is commonly added to pasteurized processed cheese spreads to 
prevent the outgrowth of clostridia spores, such as Clostridium tyrobutyricum (Schillinger 
et al., 1996). 
 
1.4.3 Biopreservation of seafood products 
 
The effectiveness of bacteriocins and protective cultures to control growth of L. 
monocytogenes in vacuum-packed coldsmoked salmon has been demonstrated by 
several researchers. 
Katla and co-workers (2001) examined the inhibitory effect of sakacin P and/or L. sake 
cultures (sakacin P producer) against L. monocytogenes in cold-smoked salmon. 
Sakacin P had an initial inhibiting effect on growth of L. monocytogenes while cultures of 
L. sake had a bacteriostatic effect. When L. sake culture was added to salmon together 
with sakacin P, a bacteriocidal effect against L. monocytogenes was observed.  
The inhibitory effect of nisin in combination with carbon dioxide and low temperature on 
the survival of L. monocytogenes in cold-smoked salmon has also been investigated 
(Nilsson et al., 2000). Addition of nisin to salmon inoculated with L. monocytogenes and 
stored at 5 °C delayed, but did not prevent growth of L. monocytogenes in vacuum-
packs. Addition of nisin to CO2-packed cold-smoked salmon resulted in one to two 
oreders of magnitude reduction of L. monocytogenes.  
In order to improve shelflife, brined shrimp are typically produced with the addition of 
sorbic and benzoic acids. Concerns about the use of these organic acids have led 
researchers to explore the potential of using bacteriocins for their preservation. The 
effectiveness of nisin Z, carnocin UI49, and a preparation of crude bavaricin A on 
shelflife extension of brined shrimp was evaluated by Einarsson and Lauzon (1995) 
demonstrating how the inhibition by bacteriocin multiple addition is comparable to 
organic acids effects. 
 
1.4.4 Nisin 
 
Nisin is 34–amino acid peptide produced by strains of Lactococcus lactis and is the best 
studied representative of the lantibiotics (Klaenhammer T.R., 1993). At least 6 different 
forms have been discovered and characterized (designated as A through E and Z), 
being nisin A the most active type. Nisin usually has no effect on Gram-negative 
bacteria, yeasts and moulds, although Gram-negative bacteria can be sensitized to nisin 
by permeabilization of the outer membrane layer as caused by heating, freezing, and 
chelating agents (Delves-Broughton et al., 1996). Normally only Gram-positive bacteria 
are affected, and these types include LAB, pathogens such as Listeria, Staphylococcus, 
and Mycobacterium, and the sporeforming bacteria, Bacillus and Clostridium.  
In 1928, Rogers and Whittier first published on the inhibitory effect of nisin in which 
Streptococcus lactis (now Lactococcus lactis subsp. lactis) inhibited Lactobacillus 
bulgaricus in milk. The name nisin was coined by Mattick and Hirsch (1947) from “N 
inhibitory substance” since L. lactis was originally classified as Lancefield serological 
group N Streptococcus. Hirsch and co-workers (1951) first examined the potential of  
nisin as a food preservative. In 1957, Aplin and Barrett developed commercial 
preparations containing nisin for use in foods (Delves-Broughton et al., 1996). Finally, 
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international acceptance of nisin was given in 1969 by the Joint Food and Agriculture 
Organization/World Health Organization (FAO/WHO) Expert Committee on Food 
Additives. Currently, It has been accepted as a food additive in approximately 50 
countries.  
The largest producer is still Aplin & Barrett Ltd (Dorset, England, a subsidiary of Cultor 
Food Science, Ardsley, New York, USA), which markets a standardized preparation of 
nisin, NisaplinTM, with the active ingredient 2.5% nisin A and the predominate ingredients 
NaCl and skimmed dry milk. In the current industrial process, pasteurized milk plus 
added yeast extract is treated with a protease and used as a substrate in batch 
fermentation at controlled pH and temperature. An extraction process, including a spray-
drying step, follows and the resulting powder is standardized with NaCl. Further 
purification is expensive and not commercially valuable for food use. A standardized 
nisin preparation (Chrisin) is also marketed by Chr Hansen (Hùrsholm, Denmark). 
Examples of international food products that legally can be amended with nisin are 
canned soups (Australia), ice for storing fresh fish (Bulgaria), clotted cream (UK) and 
milk shakes (Spain); however, the majority of approved product types are dairy products 
(especially cheeses) and canned goods (Guder et al., 2000).  
In the U.S., use of nisin-producing starter cultures has never been regulated, as 
lactococci are considered GRAS. As inferred from the FDA Code of Federal Regulations 
(1988) regarding use of bacteriocins as food additives, when natural antimicrobials (that 
is, bacteriocins such as nisin) are used as food preservatives, the producing culture 
must be considered a GRAS microorganism (see nextly, “Regulatory considerations”).  
 
1.4.5 Use of bacteriocins in hurdle technology 
 
The major functional limitations for the application of bacteriocins in foods are their 
relatively narrow activity spectra and moderate antibacterial effects. To overcome these 
limitations, more and more researchers use the concept of hurdle technology to improve 
shelflife and enhance food safety (Chen and Hoover, 2003; Leistner L., 2000). Hurdle 
technology combines different preservation methods to inhibit microbial growth. For 
example, they are generally not active against Gram-negative bacteria. Indeed, it is well 
documented that Gram-negative bacteria become sensitive to bacteriocins if the 
permeability barrier properties of their outer membrane are impaired. For example, 
chelating agents, such as EDTA, can bind magnesium irons from the lipopolysaccharide 
layer and disrupt the outer membrane of Gram-negative bacteria, thus allowing nisin to 
gain access to the cytoplasmic membrane (Zhang and Mustapha, 1999). 
It is well documented that nisin enhances thermal inactivation of bacteria, thus reducing 
the treatment time and resulting in better food qualities. For example, Boziaris and co-
workers (1998) found that addition of nisin (500 to 2500 IU·ml-1) in media, liquid whole 
egg, or egg white caused a reduction of required pasteurization time up to 35%. Budu-
Amoako and co-workers (1999) found that nisin reduced the heat resistance of L. 
monocytogenes in lobster meat and significantly reduced the treatment time compared 
with thermal treatment alone. The reduced heat process resulted in significant reduction 
in drained weight loss that would allow considerable cost savings. 
The synergistic effect between bacteriocins and other processing technologies on the 
inactivation of microorganisms has also been frequently reported in the literature. 
Schlyter and co-workers (1993) reported synergistic effects between sodium diacetate 
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and pediocin against L. monocytogenes in meat slurries.  
Zapico and co-workers (1998) showed a synergistic effect of nisin and the 
lactoperoxidase system on inactivation of L. monocytogenes in skim milk. Addition of 
nisin and lactoperoxidase system resulted in counts of L. monocytogenes up to 5.6 
orders of magnitude lower than the control milk after 24 h at 30 °C, while nisin alone had 
no effect on the counts. The use of combinations of various bacteriocins has also been 
shown to enhance antibacterial activity (Hanlin et al., 1993). When used in combination 
with nisin, leucocin F10 provides greater activity against L. monocytogenes (Parente et 
al., 1998). 
There has been continued interest in the food industry in using nonthermal processing 
technologies, such as high hydrostatic pressure (HP) and pulsed electric field (PEF) in 
food preservation. It is frequently observed that bacteriocins, in combination with these 
processing techniques, enhance bacterial inactivation (Terebiznik et al., 2000). In 
addition, Gram-negative bacteria that are usually insensitive to LAB bacteriocins, such 
as Escherichia coli O157:H7 and Salmonella typhimurium, become sensitive following 
HP/PEF treatments that induce sublethal injury to bacterial cells (Kalchayanand et al., 
1994).  
 
1.4.6 Regulatory considerations 
 
From a regulatory standpoint, it is critical to distinguish bacteriocins from antibiotics, 
since the presence of antibiotics in food is often prohibited. For example, in Denmark, 
bacteria used to produce food additives must not produce toxins or antibiotics 
(Cleveland et al., 2001).  
The use of bacteriocin-producing starter cultures as ingredients may not require special 
consideration in the United States if the culture (microrganism) is considered GRAS, 
because of its history of safe use by food industries prior to the 1958 Food Additives 
Amendment (Muriana P., 1996).  
If a purified bacteriocin is used as a food preservative, the substance might be self-
affirmed as GRAS by the company according to the Code of Federal Regulations (U.S. 
Government Printing Office, 1990), but the Food and Drug Administration (FDA) may 
require justification of the affirmation.  
With the formation of the European Union, food additives have been given “E” numbers. 
Nisin is listed as E234, and may also be labeled as “nisin preservative” or “natural 
preservative”. 
In the United States, where antibiotics are prohibited in foods, nisin was confirmed 
Generally Recognized as Safe in 1988 (U.S. Food and Drug Administration). Several 
authors have outlined issues involved in the approval of new bacteriocins for food use 
(Post R., 1996) and the USDA publishes guidelines for the safety assessment of a new 
preservative (U.S. Food and Drug Administration, 1993). The Food Safety and 
Inspection Service (FSIS) of the USDA evaluates the safety and effectiveness of 
bacteriocins in commodity segments such as meat and poultry products. Thus 
depending on the type of product, the FDA or FSIS approve use of novel bacteriocins 
before any applications are permitted (Chikindas and Montville, 2002). 
For approval to be granted, the bacteriocin must be chemically identified and 
characterized, and its use and efficacy must be shown. The manufacturing process must 
be described and assays used for quantification and standardization of the peptide must 
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be shown. Toxicological data and the fate of the molecule after ingestion are also 
needed.  
 
1.5 Bacteriocins produced by Enterococcus spp. 
 
The genus Enterococcus comprises up to date 26 different species, with Enterococcus 
faecium and Enterococcus faecalis being the two species mostly found (Klein G., 2003). 
They are traditionally considered part of LAB. Especially their ubiquitous occurrence and 
their habitats in the intestinal tract of mankind and a variety of farm animals as well as in 
different sorts of food and feed are typical for LAB.  
In particular, enterococci frequently occur in some cheeses (Sarantinopoulos et al., 
2002; Giraffa G., 2003), above all in those produced in Mediterranean countries, such as 
Feta and Mozzarella, and in meats (Hugas et al., 2003), such as dry fermented 
sausages. In these foods, they are considered as either a contamination from the 
environment or a natural starter culture, contributing to the processing and the 
development of the organoleptic properties of the product. Moreover, Enterococcus spp. 
are occasionally used as probiotics (Franz et al., 2003). 
Interestingly, many strains of enterococci are known to produce bacteriocins. These are 
called enterocins or enterococcins and they generally belong to class II (Giraffa G., 
1995). The enterocins are generally active against other enterococci as well as strains of 
Listeria monocytogenes and Clostridium spp., including C. botulinum, C. perfrigens and 
C. tyrobutyricum. The anti-Listeria activity may be explained by the fact that enterococci 
and listeriae are phylogenetically closely related (Devriese and Pot, 1995). Bacteriocin-
producing Enterococcus strains with strong anti-Listeria activity have been isolated from 
dairy products (Giraffa G., 2003), fermented sausages (Hugas et al., 2003), fish (Ben 
Embarek et al., 1984), vegetables (Bennik et al., 1998) and fermented olives (Franz et 
al., 1996). 
Examples of the best characterised enterocins are enterocin A, a class IIa, pediocin-like 
bacteriocin (Aymerich et al., 1996),  and enterocin B (Casaus et al., 1997), a bacteriocin 
that is not pediocin-like, but it is similar to the class IIa bacteriocins because of its 
chemical characteristics, heat stability and anti-Listeria activity. Enterocin P belongs to 
class IIc because secretion occurs by the sec-pathway (Cintas et al., 1997). Enterocins 
L50A and L50B have intrinsic antimicrobial activity, but interestingly together they show 
synergistic activity. They are not post-translationally modified and do not require the 
presence of a leader or signal peptide for secretion (Cintas et al., 1998). 
The application of bacteriocins produced by enterococci and of bacteriocin-producing 
Enterococcus starters or protective cultures is well documented in cheese and meat 
manufacture. Bacteriogenic E. faecium was tested for use in combination with a 
commercial starter culture for Taleggio cheese making (Giraffa G., 1995). Bacteriocin 
was produced during drainage in the cheese until the end of the ripening period, while 
growth of the commercial starters was not inhibited. Hugas and co-workers (2003) 
reported that the production of enterocin A and B by E. faecium CTC492 was very low in 
the typical conditions of sausage manufacturing. Despite this, the addition of these 
enterocins to the fermented sausages spiked with Listeria monocytogenes significantly 
diminished Listeria counts compared with the control. Other bacteriogenic strains of E. 
faecium (RZS C13 and CCM4231) and E. faecalis AS48 were assayed as anti-listerial 
protective cultures in real or model sausage fermentations (Callewaert et al., 2000). All 
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Enterococcus strains inhibited Listeria further than the positive control. 
Based on these studies and due to their strong activity against Listeria spp., potential 
approaches of food preservation using enterocins-producing protective enterococci or 
purified enterocins as biopreservatives are very promising. 
 
1.6 Productive processes of bacteriocins 
 
Altough many food preservation applications exploiting the ability of producing 
bacteriocin by LAB use protective cultures (production in situ), these approaches are 
limited by a number of factors (Schillinger et al., 1996). First of all, environmental 
parameters necessary for food production (e.g. pH, temperature, nutrients) might be not 
suitable for bacteriocin synthesis and/or release. Moreover, the spontaneous loss of 
bacteriocin-producing ability and the inability to release sufficient quantities of the 
bacteriocin to suppress undesired bacteria in food environment are also key factors to 
be considered in the development of a protective culture. Other limits to this approach 
are eventual phage infection of the producing culture and the antagonism by the other 
bacteria present in food, thus inhibiting the microrganism growth and consequently the 
bacteriocin production. Potential deleterious effects of the protective cultures on the 
sensorial qualities and the consumer health (e.g. by toxins or biogenic amines 
production) are also drawbacks to be overcome. 
Due to these limits, most studied and preferred applications recently imply the direct 
addition of semi-purified or (better) purified bacteriocin as food biopreservative. 
In order to make the commercial use of these bacteriocin preparations effective, the 
development of an appropriate fermentative process is required to obtain high yield of 
product. In parallel, an economically feasible strategy for purification of the bacteriocin 
from the fermentation broth has to be studied and optimized. 
 
1.6.1 Fermentative processes of bacteriocins 
 
1.6.1.1 Kinetics of bacteriocin production 
 
Generally, bacteriocin production shows primary metabolite kinetics, starting as soon as 
cell growth begins and ceasing at or immediately before the end of cell growth (Parente 
et al., 1997). This implies that the bacteriocin production is dependent on the total 
biomass formation. However, a high cell yield does not necessarily results in a high 
bacteriocin activity since the latter may be limited by a low specific bacteriocin 
production, i.e. a low bacteriocin production per gram of cells (Leroy and De Vuyst, 
1999). Hence, a rather complex relationship between environmental conditions and 
bacteriocin production exists. An interesting example of this behaviour is purchased by 
Leroy and De Vuyst (2002). They demonstrated that enterocin production by E. faecium 
RZS C5 grown on MRS medium at pH 6 in batch modality is limited to the very early 
growth phase and is switched off at a well defined cell density. On the other hand,  at 
constant pH values higher than 6.5, enterocin production is lower but maintained until 
the end of the exponential phase. This behaviour suggests as the enterocin production 
is strongly regulated. 
After reaching a maximal bacteriocin activity during the exponential growth phase, a 
drastic decrease in bacteriocin activity often occurs as a consequence of proteolytic 
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inactivation, protein aggregation and pH-dependent adsorption of the bacteriocin 
molecules to the cell surface of the producer cells (Yang et al., 1992). Since adsorption 
of bacteriocins to cells is maximal at pH 5.5-6.5 and decreases at low pH, it is not 
surprising that no reduction of bacteriocin titre is sometimes observed in fermentations 
without pH control (Yang and Ray, 1994). 
 
1.6.1.2 Factors affecting bacteriocin production in LAB 
 
Any factors increasing cell growth should increase bacteriocin production, but the yield 
of bacteriocin per unit of biomass is strictly affected by several factors (Parente and 
Ricciardi, 1999), including the producing strain, media (carbohydrate and nitrogen 
sources, cations, etc.) and fermentation conditions (pH, temperature, stirring, aeration, 
feeding profile in fed-batch fermentations and dilution rate in continuous fermentations). 
 
Microbial strain. A given bacteriocin can be produced by several strains or species (Jack 
et al. 1995). Yang and Ray (1994) found that nisin and leuconocin Lcm1 production 
varied among different strains, while pediocin AcH showed less variation. De Vuyst L. 
(1994) screened 21 nisin-producing and 6 non-producing strains of L. lactis for nisin 
production and immunity. Nisin titres varied from 1 to 1886 IU·ml-1 and did not correlate 
with the number of copies of the genes or with their transcription or translation levels. 
Differences among strains were attributed to expression level and activity of maturing 
enzymes and, to a lesser extent, to nisin immunity.  
 
Media. Bacteriocin production is deeply affected by type and level of the carbon, 
nitrogen and phosphate sources, cations, surfactants and inhibitors (Parente and 
Ricciardi, 1999). 
Since LAB are nutritionally fastidious microorganisms, growth and bacteriocin production 
is often increased in complex media (e.g. MRS). In a recent work, Todorov and Dicks 
(2006) evaluated the bacteriocin production by two strains (ST23LD and ST341LD) in 
different media and pH conditions. They observed that addition of tryptone, yeast extract 
and meat extract to a basal medium constituted by MRS have beneficial effects on the 
bacteriocin production. Comparison of bacteriocin production by some probiotic LAB in 
MRS and milk-based medium showed a greater production in the first one (Avonts et al., 
2004). Nevertheless, the addition of yeast extraxt to the milk can enhance the 
bacteriocin production. 
 
Effect of fermentation conditions. Since pH and temperature control improve the growth 
of LAB, it also results in improved bacteriocin production. However, the optimal pH for 
bacteriocin production is usually 5.5-6 (Parente and Ricciardi, 1999), often lower than 
the optimal pH for growth. On the other hand, growth at optimal temperature usually 
results in optimal bacteriocin production but temperature stress and growth at sub-
optimal temperature may result in an increase of bacteriocin yield per biomass unit 
(Lejeune et al., 1998). 
Agitation and aeration also affect bacteriocin production. Increases of these parameters 
often result in decrease of bacteriocin activity, perhaps because of chemical degradation 
and effects on gene expression (Parente and Ricciardi, 1999). 
Researchers generally exploit batch fermentations to find best conditions (pH, T, 
  
 34                    
aeration and agitation) for bacteriocin production, also exploiting mathematical 
modeling. Leal-Sánchez and co-workers (2002) optimized conditions (glucose and NaCl 
concentrations, inoculum size, aeration and temperature) of batch fermentation of 
Lactobacillus plantarum LPCO10 using a statistical approach; under optimal conditions, 
a substantial improvement of product was achieved. 
Batch fermentations were also used to optimize pH and temperature for bacteriocin 
production by Lactobacillus curvatus LTH 1174 and to validate a model that describes 
the influence of these parameters on microbial behaviour (Messens et al., 2003). 
These studies demonstrate that batch fermentations are useful to find the cultural 
conditions that maximize bacteriocin production, but the overall product yield remains 
low. Differently from batch fermentations, where the bacteriocin production ceases at the 
end of growth phase, a way to improve bacteriocin production is the fed-batch 
fermentation technology, that allows to obtain high cell densities through the supply of 
fresh medium. Fed-batch fermentations to improve bacteriocin production were 
described for nisin, gallidermin and epidermin (Ungermann et al., 1991). In these works, 
an appropriate feeding strategy allows to enhance the bacteriocin production. 
Interestingly, Callewaert and De Vuyst (2000) found that production of amylovorin L471, 
a bacteriocin produced by Lactobacillus amylovorus DCE 471, is improved and 
stabilized in fed-batch fermentation if substrate addition is controlled by acidification rate 
of the culture. A comparison of the performance of different fermentation strategies 
(flask, batch and fed–batch with constant or exponential feeding) on growth and 
bacteriocin production by L. curvatus CWBI-B28 was done by Ghalfi and co-workers 
(2007); the best bacteriocin activity was obtained in a very rich medium fed into 
bioreactor following an exponential profile.  
Occasionally, continuous cultures were also applied to study the effect of growth rate on 
bacteriocin production (Parente et al., 1997; Bárcena et al., 1998). A linear relationship 
is often observed between dilution rate (D) and bacteriocin production rate. Increase in 
D results in a decrease of biomass and bacteriocin concentration, a high substrate 
concentration in the effuent, and eventually wash-out of the culture. Therefore, 
continuous fermentation with cell recycle or with immobilized cells has been tested by 
some authors. Continuous fermentation coupled with cell recycle with L. lactis subsp. 
lactis IFO12007 led to an increase in nisin level and volumetric nisin productivity 
compared to batch fermentations (Taniguchi et al., 1994). Wan and co-workers (1995) 
compared nisin, brevicin 286 and pediocin PO2 production with free or Ca-alginate 
immobilized cells. In repeated batch fermentations, immobilized cells produced less 
bacteriocin than free cells, perhaps because of diffusional limitations of the substrate in 
alginate gels.  
An interesting comparison of different reactor designs to improve bacteriocin productivity 
was performed by Bhugaloo-Vial and co-workers (1997). Three different reactors (a 
chemostat with free cells, a chemostat with cells immobilized in calcium-alginate beads, 
and a membrane bioreactor) were used, showing that immobilized cells presented the 
best performances in terms of bacteriocin productivity and concentration. 
 
1.6.2 Downstream processes of bacteriocins 
 
The use of bacteriocins as biopreservatives directly added to foods requires the 
development of a simple and rapid method by which large quantities of product may be 
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purified from fermentation broths. Bacteriocin properties (cationic and hydrophobic 
nature, low molecular weight) can be exploited for their recovery from complex 
fermentation broths which contain high levels of peptides (10-30 g·L-1) compared to a 
bacteriocin concentration of 10-100 mg·L-1. 
Carolissen-Mackay and co-workers (1997) have rewieved protocols for lab-scale 
purification of bacteriocins from many LAB, namely Lactobacillus, Leuconostoc, 
Pediococcus, Carnobacterium and Lactococcus spp. The methods reported in this 
review, mostly used for purification of cationic bacteriocins, generally include a 
centrifugation step for the removal of cells from the bacterial culture medium, followed 
by a concentration step. The latter often involves precipitation of peptides with 
ammonium sulphate and precipitate recovery by centrifugation. The bacteriocin is 
subsequently purified to homogeneity by one or more chromatographic steps, including  
cation-exchange, hydrophobic interaction, gel permeation and/or reverse-phase 
chromatography.  
For example, enterocin RJ-11 produced by Enterococcus faecalis RJ-11 (Yamamoto et 
al., 2003) and piscicocin CS526 produced by Carnobacterium piscicola CS526 
(Yamazaki et al., 2005) were purified to homogeneity by centrifugation, ammonium 
sulphate precipitation and gel permeation chromatography on Sephadex G50 column, 
while reverse-phase chromatography was used to purify enterococcin EFS2 (Maisnier-
Patin et al., 1996) and enterocin 4 (Joosten et al., 1996). 
However, the primary aim of these studies consists in obtaining purified preparations of 
bacteriocin in order to biochemically characterize them, e.g. determining molecular 
weight, amino acid sequence, mode of action, etc.. Indeed, these downstream 
processes are applicable only on small volumes and are characterized by very low  
overall yield (about 50 % but often less than 30 %). In order to increase the product 
yield, Guyonnet and co-workers (2000) substituted ammonium sulphate precipitation 
with cation-exchange chromatography to purify mesentericin Y105 by Leuconostoc 
mesenteroides Y105 broth and other five anti-Listeria bacteriocins; however, a 
purification from a 100 mL culture with a final yield of 60 % took 6 to 8 h.  
Uteng and co-workers (2002) proposed a rapid and simple two-step chromatographic 
procedure suitable for both small- and large-scale purification of class IIa bacteriocins. In 
the first step the bacterial culture is directly applied on a cation-exchange column; 
nextly, the bacteriocin fraction is purified on a reverse-phase column. Yield and purity of 
pediocin PA-1 purified with this method were 80 and 90 %, respectively.  
Besides chromatographic steps, other methods to purify bacteriocin use organic 
solvents. Lactococcin B and pediocin PA-1 were purified in a rapid way by ethanol 
precipitation, preparative isoelectric focusing and ultrafiltration (Venema et al., 1997). 
The authors suggested that their method could be applicable with success to small, 
hydrophobic and cationic bacteriocins.  
A sequence of ammonium sulphate precipitation, chloroform/methanol extraction and 
reverse-phase chromatography was applied to purify amylovorin L471 from 
Lactobacillus amylovorus DCE 471 broth (Callewaert R., 1999). Chloroform/methanol 
extraction was also used to partially purify seven enterocins by E. faecium and faecalis 
strains (Foulquié Moreno et al., 2003), showing as it could be a general method to purify 
bacteriocins. 
Several protocols based on adsorption/desorption have been developed for large scale 
recovery and purification of bacteriocins. As mentioned above, bacteriocin produced 
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after growth phase adsorb to the membrane of cell producer. This effect can reduce free 
bacteriocin available for the subsequent purification (Jack et al., 1995). The pH is a 
crucial factor in determining the degree of adsorption of the peptide onto cell surface. In 
general, large amounts (until 90 %) of bacteriocin molecules are adsorbed at pH near 6, 
whereas the lowest adsorption (< 10 %) took place at pH near 2. On the basis of this 
information, Yang and co-workers (1992) developed a downstream processing for four 
bacteriocins (nisin, pediocin AcH, sakacin A and leuconocin Lcm1) adsorbing on the cell 
surface. It consisted in pasteurizating the culture to kill the producing cells after 
fermentation, a culture pH adjustment to 6 to allow bacteriocin adsorption, harvesting of 
cells and their re-suspension in a pH 2 buffer to release the bacteriocin molecules from 
the cell surface. With this procedure, yields greater than 95 % has been achieved. The 
resulting material provides a convenient starting point for subsequent bacteriocin 
purification. However, the recovery may be limited for other strain/bacteriocin 
combinations (Daba et al. 1994).  
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AIMS OF THE WORK 
 
The primary aim of this research project was to study bacteriocin production from 
specific lactic acid bacteria. Particularly, most activity was focused on the development 
and optimization of bacteriocin production process by an enterococcal strain 
(Enterococcus casseliflavus CGA1) isolated from “salami” meat. In collaboration with a 
biotech company active in food industry that made us the strain available, we 
demonstrated that this enterocin has a strong activity towards Listeria monocytogenes; 
therefore it is potentially interesting as food biopreservative.  
In order to satisfy this goal, the following topics were planned: 
• cost optimization of a growth medium suitable for enterocin production and 
microorganism growth; 
• study of bacteriocin production kinetics in relation to the microorganism growth 
and metabolism in batch fermentation; 
• development of fed-batch fermentative processes for bacteriocin production; 
• development of a novel downstream process for purification of the bacteriocin 
from fermentation broth; 
• scale up studies of the process from 2 to 100 liters. 
A spectrum activity versus starter cultures/probiotics LAB and different pathogens was 
also defined.  
Moreover, other LAB, used as starter cultures and/or probiotics, were screened for 
production of bacteriocins active towards pathogens. Namely, the strains Lactobacillus 
plantarum DSM 12028 and Lactobacillus crispatus L1 were used in this research work. 
Their bacteriocin production towards pathogenic microorganisms was studied in flask 
and batch fermentations.   
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2. MATERIALS AND METHODS 
 
2.1 Materials 
 
Growth media components, ammonium sulphate and ethylene diamino tetraacetic acid 
(EDTA) were supplied by Sigma Aldrich (USA).  
Tryptic Soy Broth (TSB), bacteriological agar and de Man-Rogosa-Sharp (MRS) medium 
were purchased by Oxoid (United Kingdom). 
Vegetable peptone E1, soy peptone A2SC, soy peptone E110, wheat peptone E430, 
meat extract and yeast extract were supplied by Organochemie (France). 
 
2.2  Strains and media 
 
The enterococcal strain used in this work was Enterococcus casseliflavus CGA1, 
isolated from industrial “salami” production by an Italian company and characterized by 
API 20 NE bioMerieux (France) in our department. The other LAB tested for bacteriocin 
production were probiotic strains Lactobacillus plantarum DSM 20128 purchased by 
DSMZ (Deutsche Sammlung von Mikroorganismen und Zellkulturen Gmb H, Germany) 
and Lactobacillus crispatus L1, human isolated by vaginal secretions and previously 
characterized by API 20 NE bioMerieux. 
The producing strains were stored on agar plates at 4 °C and in a 20% v/v glycerol 
solution at -80 °C.  
The basal medium, whose formulation was also suggested by the industry, used for E. 
casseliflavus CGA1 growth is shown in Table 5. The salts stock solution, stored at 4 °C, 
was composed as follows: MgSO4⋅7H2O, 20 g·L-1; MnSO4⋅H2O, 5 g·L-1; CaCl2⋅2H2O, 10 
g·L-1; FeSO4⋅7H2O, 2 g·L-1; CuSO4⋅5H2O, 0.1 g·L-1; CoCl2⋅6H2O, 0.08 g·L-1; 
ZnSO4⋅7H2O, 0.8 g·L-1; Na2MoO4, 0.08 g·L-1; EDTA⋅2Na, 35 g·L-1. 
The vitamin solution was prepared re-suspending one tablet of commercially obtained 
BeTotal in 100 mL of deionised water, filtered on 0.22 μm (Millipore, USA ) and stored at 
4 °C. 
L. plantarum DSM 12028 and L. crispatus L1 were grown on a semi-defined medium 
(Kimmel and Roberts, 1998), eventually modified in the concentration of bactocasitone 
(Difco, France) as previously described by Schiraldi and co-workers (2003).  
The microorganisms used as indicators to assay bacteriocin activity, and their growth 
media and temperatures are reported in Table 6. 
Medium components were thermally sterilized in autoclave (120 °C for 15 min) except 
glucose and vitamin solution that were filtered on 0.22 μm filter devices (Millipore, USA) 
and added afterwards. 
 
2.2.1 Agar plates preparation 
 
To maintain the producing strains, agar plates were prepared using MRS medium with 
the addition of 20 g·L-1 of agar. Petri dishes were stricken with a cell suspension and 
then were incubated at 37 °C overnight (except L. plantarum DSM 12028 that was 
grown at 30 °C) and stored at 4 °C if necessary.  
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Nutrient 
 
Concentration 
 
Glucose 
 
20 g·L-1 
 
N complex source 
 
20 g·L-1 
 
Ammonium citrate 
 
13 g·L-1 
 
NaCl 
 
6 g·L-1 
 
KH2PO4 
 
2 g·L-1 
 
Salts 
 
20 mL·L-1 (from stock solution)
 
Complex B vitamins 
 
 
2 mL·L-1  (from  stock solution)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Indicator microorganims 
 
Growth medium 
 
Temperature (°C) 
 
Enterococcus faecium F1 
 
Tryptic Soy Broth 
 
30  
 
Lactobacillus casei  DSM 20011 
 
MRS broth 
 
37  
 
Lactobacillus bulgaricus DSM 21081
 
MRS broth 
 
37  
 
Lactobacillus crispatus L1 
 
MRS broth 
 
37  
 
Lactococcus lactis NZ9000 
 
M17 broth 
 
30  
 
Lactobacillus plantarum DSM 12028
 
MRS broth 
 
30  
 
Escherichia coli BL21 
 
Luria-Bertani medium
 
37  
 
Escherichia coli K4 
 
Luria-Bertani medium
 
37  
 
Listeria monocytogenes 
 
Tryptic Soy broth 
 
37  
 
Staphylococcus aureus 
 
Luria-Bertani medium
 
37  
 
Streptococcus agalactiae 
 
Luria-Bertani medium
 
37  
 
Klebsiella pneumoniae 
 
Luria-Bertani medium
 
37  
Table 5 
Basal growth medium for E. casseliflavus 
CGA1. 
Table 6 
Indicator microorganisms used in this work. 
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2.3 Flask experiments 
 
Flasks experiments, performed in order to optimize the growth medium for E. 
casseliflavus CGA1, were carried out in a rotary air shaker (model Minitron, Infors, 
Switzerland) at 37°C, with a rotation speed of 50 rpm using 250 mL flasks. The 
medium/shake flask volume ratio was kept equal to 1.6. The medium was inoculated 
with a glycerol stock solution and growth kinetics, like in the other experiments, was 
evaluated by the determination of the absorbance at 600 nm (Spectrophotometer 
DU800, Beckman Coulter, USA). 
At regular time intervals (generally 1 hour), samples were collected, centrifuged at 
1700xg (centrifuge model: Avanti J-20 XP, Beckman Coulter, USA), and tested for 
bacteriocin activity. 
Flask experiments were also performed to study the effect of medium on the bacteriocin 
production from L. plantarum DSM 12028 and L. crispatus L1. They were carried out 
through the procedure described above. 
 
2.4 Fermentation experiments 
 
For fermentation experiments, three fermenters (Biostat CT, Biostat C and Biostat D; 
Braun Biotech International, Germany) with different volume  were used. 
The Biostat CT is a fermenter with a working volume of 2 L; the Biostat C has a working 
volume of 15 L; the Biostat D working volume is 100 L. They are in situ sterilizable and 
connected to a DCU (Digital Control Unit) to set and control different parameters as pH, 
pO2, stirring speed (rpm), air flow rate (L·min-1) and temperature (°C). Moreover, the 
fermenters were connected to a PC and remotely controlled by the MFCS-win software. 
The systems were provided with four peristaltic pumps for the addition of alkali, acid and 
nutrients, and with temperature, pH and pO2 probes.  
Each fermentation experiment was performed on triplicate. 
 
2.4.1 Batch fermentations 
 
Batch experiments performed with E. casseliflavus CGA1 were first carried out in the 2 L 
Biostat CT described above. 2 L of optimized medium in the fermenter were inoculated 
from seed cultures overnight grown so that the starting absorbance (600 nm) value was 
kept between 0.08 and 0.12. The pH was always set and kept constant at 7 by adding 
NH4OH 30 % (v/v) or H2SO4 30 % (v/v). The temperature and stirring speed were also 
kept constant at 37 °C and 50 rpm, respectively. The fermentations were performed 
without aeration. 
During the cultivations, 5 mL samples were withdrawn from the reactor at regular time 
intervals for the determination of absorbance at 600 nm, bacteriocin activity, glucose 
and lactic acid concentrations. Using a conversion factor of 0.52, OD values were 
converted in dry biomass concentrations (X, g·L-1), as previously reported for lactic acid 
bacteria (Schiraldi et al., 2003).    
Batch experiments were reproduced, in scaling up experiments, on Biostat C and 
Biostat D fermenters. Culture volumes were 15 and 100 L, respectively. The process 
conditions (temperature, pH, stirring) were the same. 
Batch experiments on 2 L scale were also performed to assay the bacteriocin production 
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from L. plantarum DSM 12028 and L. crispatus L1. 2 L of appropriate medium were 
inoculated using the procedure described above. The pH was kept constant at 6.5 for 
both microorganisms, while the temperature was 30 °C for L. plantarum DSM 12028 and 
37 °C for L. crispatus. Stirring was set at 100 rpm. The fermentations were performed 
without aeration. Samples (5 mL) were regularly withdrawn from the fermenter for the 
determination of absorbance at 600 nm and bacteriocin activity.  
 
2.4.2 Fed-batch fermentations 
 
Fed-batch experiments for E. casseliflavus CGA1 were firstly carried out on the 2 L 
fermenter. Two different fed-batch strategies (pulse and continuous feeding) were 
implemented. 
In the pulse feeding experiments, the batch phase last 5 h, then pulses of fresh 
concentrated medium were done at 5, 7 and 9 h. The medium was concentrated in order 
to give, after the addition in the culture volume, the initial concentrations of each 
component. 
In the continuous feeding experiments, after 5 h of batch phase, a fresh concentrated 
medium was fed into bioreactor. The feeding strategy was designed according to the 
following equations:     
 
       
 
iS
sXVqF =
 
                                                                
 
 
xsYsq μ=  
 
 
 
In these equations, F is the feed flow rate (L·min-1), X is the initial biomass concentration 
(g·L-1), V is the starting colture volume (L), qs is the specific substrate consumption (g·g-
1·h-1), Si is the limiting substrate concentration in the feeding solution (g·L-1), μ is the 
specific growth rate (h-1), and YX/S is the yield coefficient of biomass on substrate (g·g-1). 
In our experiments, glucose (carbon and energy source) was the limiting substrate. F 
was set hour per hour from glucose consumption using these equations.   
The concentrated feeding solution contained 200 g·L-1 of glucose, 25 g·L-1 of soy 
peptone A2SC, and the other nutrients at the concentrations reported in Table 5.  
For the duration of all cultivations, 5 mL samples were withdrawn from the reactors at 
regular time intervals.  
Only the fed-batch experiments based on continuous feeding strategy were reproduced 
on 15 and 100 L fermenters, to test the scalability of the process. 
 
(eq. 1) 
(eq. 2) 
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2.5 Downstream processes 
 
At the end of fed-batch fermentations, 2 L culture broth was centrifuged at 5000xg at 4 
°C for 40 min (centrifuge model: Avanti J-20 XP, Beckman Coulter, USA) and the 
supernatants were collected and submitted to different downstream procedures. 
 
2.5.1 Purification procedure with buthanol/acetone 
 
The supernatant was acidified at pH 1.5 with 1 M HCl. 200 mL of buthanol and 600 g of 
NaCl were added; the extraction with buthanol was performed for 3 h under stirring. The 
phase separation was carried out by a separating funnel. The organic phase (1/10 of the 
initial volume) was collected, while the water one was extracted again (1.5 h), after 
adding of 100 mL of buthanol; the second organic phase was added to the first one. 500 
mL of acetone were added; the precipitation with acetone was performed  for 2 h, at 4 
°C, under stirring. The wet solid was recovered by filtration using a filter cloth and dried 
under vacuum, for 4 h, at 40 °C. At the end of each phase, samples were collected and 
tested for bacteriocin activity and protein concentration. All reagents for this procedure 
were purchased by Sigma-Aldrich.  
This procedure is schematically represented in figure 2(a). 
 
2.5.2 Purification procedure with methanol/chloroform 
 
The enterocin was purified by lightly modifying the procedure reported by Callewaert 
and co-workers (1999).  
Supernatant pH was adjusted to 6.5 with 2 M NaOH. This cell-free culture supernatant 
was brought to a final ammonium sulphate concentration of 40 % saturation by slow 
addition of the salt, and was stirred overnight at 4 °C. Then, the mixture was centrifuged 
(5000xg, 30 min, 4 °C) and the bottom pellets and the surface pellicles were harvested 
and resuspended in 200 mL of 50 mM sodium phosphate buffer (pH 6.5). To one 
volume of the resuspended product, 15 volumes of a methanol-chloroform mixture (1:2, 
v/v) were added, and the mixture was extracted at 4 °C for 1 h. The resulting fine-
grained white precipitate (containing the product) was collected by centrifugation 
(5000xg, 30 min, 4 °C) and air dried. This partially wet precipitate was dried under 
vacuum, for 4 h, at 40 °C. At every step, samples were collected and tested for 
bacteriocin activity and proteins concentration. The reagents used were purchased by 
Sigma-Aldrich. 
The procedure described is schematically outlined in figure 2(b). 
 
2.5.3 Purification procedure based on membranes 
 
2.5.3.1 Description of equipment 
 
In order to perform and to study the enterocin purification through ultrafiltration 
membranes on 2 liters scale, tangential flow filtration ÄKTAcrossflow system (GE 
Healthcare, USA) was used. It is a completely automatized system to perform 
microfiltration/ultrafiltration operations using hollow fibers or cassettes cartridges with 
filtering area from 0.004 to 0.02 m2. The system is equipped with a sample reservoir of  
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 Fermentation Fermentation Fermentation 
Centrifugation and 
supernatant (pH 1.5)  
recovery 
Centrifugation and 
supernatant recovery 
Centrifugation and 
supernatant (pH 6.5) 
recovery 
Addition of NaCl  
and buthanol 
Addition of ammonium 
sulphate (40 %)
Ultrafiltration at 30 
kDa hollow fibers
Extraction (3 h) Precipitation (12 h, 4 °C) 
Addition of ammonium 
sulphate (40 %) to the 
permeate  
Centrifugation and pellet re-
suspension in saline buffer
Diafiltration at 3 kDa hollow 
fibers 
Drying of the retentate (4 h, 
40 °C) 
Phase separation and 
recovery of organic 
Second extraction 
of water phase 
Addition of acetone to 
the organic phases and 
precipitation (2 h, 4 °C) 
Recovery of the 
precipitate through filter-
Drying of the precipitate 
 (4 h, 40 °C) 
Centrifugation and pellet re-
suspension in saline buffer
Addition of methanol 
and chloroform
Extraction (1 h, 4 °C)
Centrifugation and recovery 
of the pellet
Drying of the pellet (4 h, 40 
°C)
Figure 2 
Schematic representation of the three enterocin downstream processes compared in 
this work. (a) buthanol/acetone procedure; (b) methanol/chloroform procedure; (c) 
purification based on membranes. 
(a) (b) (c) 
Precipitation  
(12 h, 4 °C) 
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350 mL, a transfer pump (0-200 mL·min-1) for inlet of process sample, diafiltration buffer, 
and CIP (Cleaning In Place) solutions; a feed pump (0-600 mL·min-1) for feeding of the 
sample from the reservoir to the filter and recirculation to the reservoir; a permeate 
pump (0-600 mL·min-1) to generate a back-pressure for fine TMP regulation. Moreover, it 
is equipped with a sensor level to perform fed-batch concentration or constant volume 
diafiltration; temperature probe on the retentate line; pressure sensors and flow meters 
on feed, retentate and permeate lines; and pHmeter, conductivity meter and UV (with 
λ=280 nm) detector on permeate line. It is connected to a PC and a UNICORNTM 
software, that allows to monitor and control the process and its parameters. 
 
2.5.3.2 Purification procedure with membranes 
 
The cell-free supernatant was ultrafiltered using 30 kDa hollow fiber cartridges housed 
on ÄKTAcrossflow. The membranes had a surface area of 0.014 m2 and an inner 
diameter of 0.5 mm. During the process, retentate flow rate and TMP were set constant 
at 150 mL·min-1 (cross flow rate=10.7 lpm·m-2) and 1 bar, respectively. The final 
concentration factor of the sample and the diafiltration exchange factor were 10 and 3, 
respectively. Ultrapure water (MilliQ; Millipore, USA) was used as diafiltration buffer. The 
permeate was collected and brought to a final ammonium sulphate concentration of 40 
% saturation by slow addition of the salt, and was stirred overnight at 4 °C. Then, the 
mixture was centrifuged (5000xg, 30 min, 4 °C) and the bottom pellets and the surface 
pellicles were harvested and resuspended in 200 mL of 50 mM sodium phosphate buffer 
(pH 6.5). This volume was 2-fold concentrated and diafiltered to remove salts using 3 
kDa hollow fiber cartridges housed on ÄKTAcrossflow. The membranes had a surface 
area of 0.014  m2 and an inner diameter of 0.5 mm. During the process, retentate flow 
rate and TMP were set constant at 200 mL·min-1 (cross flow rate=14.2 lpm·m-2) and 1.25 
bar, respectively. The diafiltration exchange factor to obtain a conductivity below 100 
μS·cm-1 was 10. Ultrapure water (MilliQ; Millipore, USA) was used as diafiltration buffer. 
The retentate was collected and dried under vacuum, for 4 h, at 40 °C. For every 
fraction of the purification process, samples were collected and tested for bacteriocin 
activity and proteins concentration. 
This purification procedure is schematically resumed in figure 2(c). 
 
2.5.3.3 Optimization of 3 kDa ultrafiltration process 
 
The optimal values of cross flow rate and transmembrane pressure for the concentration 
and diafiltration process on 3 kDa hollow fibers were determined through appropriate 
experiments using ÄKTAcrossflow.  
The system was put in complete recirculation modality (with both retentate and 
permeate lines returning to the reservoir). 300 mL of sample were filtered scouting five 
different TMPs (0.5, 1, 1.5, 2 and 2.5 bar) at a retentate flow of 200 mL·min-1. The same 
experiment was repeated at a retentate flow of 125 mL·min-1 and 50 mL·min-1, 
respectively. In each trial, the instrument recorded the flux value at every TMP.  
Plots of flux versus TMP at the different retentate flows were built and used to find the 
optimal conditions to perform the process. 
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2.5.3.4 Scale-up of the membrane purification procedure 
 
The purification through membranes was also performed on 10 L scale, to demonstrate 
the scalability of the process. The tangential flow filtration system used was the 
UniFlux10 (GE Healthcare, USA). It is a completely automatized pilot system to perform 
microfiltration/ultrafiltration operations using hollow fibers or cassettes cartridges with 
filtering area from 0.1 to 1 m2. The system is equipped with a sample reservoir of 10 L, a 
buffer feed pump for inlet of process sample, diafiltration buffer, and CIP (Cleaning In 
Place) solutions; and a membrane feed pump (0-10 L·min-1) for feeding of the sample 
from the reservoir to the filter and recirculation to the reservoir. Moreover, it is equipped 
with a sensor level to perform fed-batch concentration or constant volume diafiltration; 
temperature probe on the retentate line; pressure sensors and flow meters on feed, 
retentate and permeate lines; and pH meter, conductivity meter and UV (with λ=280 nm) 
detector on permeate line. It is connected to a PC and a UNICORNTM software, that 
allows to control, manage and monitor the process and its parameters.  
In order to scale up the 30 and 3 kDa ultrafiltration processes, hollow fibers with 0.2 m2 
filtering area and 0.5 mm inner diameter were used. The process conditions (cross flow 
rate and TMP) for both processes were the same used and optimized on 
ÄKTAcrossflow. 
 
2.6 Analytical methods 
 
2.6.1 Bacteriocin activity assay 
 
Samples collected during fermentation experiments of E. casseliflavus CGA1, L. 
plantarum DSM 12028 and L. crispatus or purification procedures of E. casseliflavus 
CGA1 broth were tested for bacteriocin activity by agar well diffusion assay and/or 
critical dilution assay (Parente et al., 1995).  
Twenty mL of the appropriate agar (1.5 % w/v) medium were pipetted in 90 mm Petri 
dishes and inoculated with a standardized indicator suspension growth overnight. The 
inoculum volume was chosen so that the absorbance at 600 nm was 0.1. After drying for 
30 min, four 8 mm wells were bored in each plate. 100 μl of the sample not diluted (for 
agar well diffusion assay) or 2-fold dilutions of each sample (for critical dilution assay) 
were pipetted into each well and the plates were incubated overnight at a temperature 
depending on the indicator strain. For the first method, the diameter of the inhibition 
zones was measured using a calliper. For the second one, that gives a more 
quantitative measure, the plates were checked for inhibition zones. The critical dilution 
was defined as the highest dilution that produce a definite inhibition zone. When a clear 
inhibition zone was followed by a hazy one, the critical dilution was calculated a the 
average of the two dilutions. The titer of the bacteriocin solution, expressed in BU·mL-1, 
was calculated as (1000/d) x D, where D is the critical dilution and d the dose (the 
amount of bacteriocin solution pipetted in each spot; 100 μL in our case). For growth 
experiments, bacteriocin specific production was also calculated as bacteriocin activity 
per biomass unit and expressed as BU·mL-1·OD-1. 
Agar well diffusion assay was used to test bacteriocin activity in order to define spectrum 
activity. This spectrum comprised the microorganism reported in Table 6. The inhibitory 
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activity versus E. coli strains was assayed in presence of 0.005 g·l-1 of EDTA.  
Critical dilution  assay was used in the other cases. When this test was performed, 
Enterococcus faecium F1 was always used as indicator strain to test the bacteriocin 
activity of E. casseliflavus CGA1, while Staphilococcus aureus was the indicator test for 
L. plantarum DSM 12028 and L. crispatus L1. 
 
2.6.2 Determination of enterocin molecular weight 
 
The molecular weight range of the enterocin was determinated as follows. A 4 mL 
surnatant sample obtained by the growth of E. casseliflavus CGA1 was ultrafiltered 
using 10 kDa centrifugal filter devices (YM-10 Centricon; Millipore, USA)  at 5000xg. The 
filtrate (3.5 mL) was splitted in a retentate (0.5 mL) and a further filtrate (3 mL) through 
ultrafiltration using 3 kDa centrifugal filters devices (YM-3 Centricon). Each fraction was 
diluted with deionised water to initial volume (4 mL). The retentates over 10 and 3 kDa 
and the filtrate under 3 kDa were tested for bacteriocin activity. 
Triplicate experiments were carried out. 
To estimate the purity after purification and to determinate more exactly the molecular 
weight of the enterocin, tricine-sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis (Tricine-SDS-PAGE) was carried out as described by Schägger and von 
Jagow (1987). Polyacrylamide concentrations in the stacking and separating gels were 
9.6 and 16 %, respectively. Electrophoresis was conducted at a constant voltage of 30 V 
for 1 h and 90 V for 12 h. The following standard proteins (Amersham, UK) were used: 
insulin α chain (2300 Da), insulin β chain (3400 Da), bovine trypsin inhibitor (6200 Da), 
lysozyme (14300 Da), β-lactoglobulin (18400 Da), carbonic anhydrase (29000 Da),  and 
ovalbumin (43000 Da). After electrophoresis, the gel was stained with Coomassie 
brilliant blue R-250. SDS, tricine and Coomassie were purchased by Sigma Aldrich 
(USA). 
 
2.6.3 Determination of glucose, lactic acid and protein concentrations 
 
Samples collected during fermentation experiments were centrifuged and supernatants 
were successively ultrafiltered using 10 KDa centrifugal filter devices (YM-10 Centricon) 
at 5000xg. The filtrate was employed for the quantification of consumed glucose and 
produced lactic acid.  
Glucose concentration was determined through HPAEC-PAD analysis performed with a 
chromatographer (model ICS-3000, Dionex, USA) using a Carbopac PA100 column 
(Dionex) and a pulsed amperometric detector (reference electrode Ag-AgCl; measure 
electrode Au). Components separation was performed by a gradient elution using 160 
mM NaOH and 400 mN CH3COONa as eluents with a flow rate of 1 mL·min-1. For 
quantification, a method based on external standards was used. 
Lactic acid and other organic acids present in the culture broth were analysed by 
isocratic elution with 0.1 % (v/v) phosphoric acid solution, on a Supelcogel TM C610H 
column (Supelco, USA) equipped with precartridge Supelgard C610H at 32 °C, using a 
Dionex-HPLC supplied with a P580 pump. Detection was carried out with a UV-detector 
170S at λ=210 nm. The flow rate was 0.5 mL·min-1. For quantification, a method based 
on external standards was used; the standards solution was composed by lactic, citric, 
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butyrric, isobutyrric, acetic and formic acids.  
Protein concentration was determined through the Bradford assay (Bradford, 1976) 
using a calibration curve obtained with BSA standard solutions. The reagents were 
purchased by Bio-Rad Laboratories (Germany).  
In the downstream processes, the increase in the bacteriocin specific activity (expressed 
as BU·mg-1) was calculated from antimicrobial activity (BU·mL-1) and proteins 
concentration (mg·mL-1). 
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3 RESULTS 
 
3.1 Flask experiments 
 
In order to formulate a growth medium suitable for bacteriocin production from 
Enterococcus casseliflavus CGA1, flask experiments were performed. The medium 
composition, used as base for the medium development in all experiments, is reported 
in Table 5, except when MRS was used: in this case, it completely replaced this 
medium.  
Two kinds of flask experiments were performed: first, the best complex nitrogen source 
for growth and bacteriocin production was found; second, the effect of decrease of 
carbon and nitrogen source concentrations was tested. 
Flask experiments were finally carried out to study the effect of nitrogen complex source 
on bacteriocin production by L. plantarum DSM 12028 and L. crispatus L1.  
 
3.1.1 Determination of the nitrogen complex source  
 
Vegetable peptone E1, soy peptone A2SC, soy peptone E110, wheat peptone E430, 
meat extract, yeast extract and MRS were tested in order to find the optimal complex 
nitrogen source for enterocin production from E. casseliflavus CGA1. The nutrient 
concentration (20 g·L-1) was the same in all experiments, except MRS, concentrated at 
52 g·L-1.   
In Table 7 the results of growth experiments, in terms of optical density (OD) at 600 nm, 
bacteriocin activity, and bacteriocin specific production (calculated as BU·mL-1·OD-1) are 
summarized; bacteriocin activities are calculated at 8 h, while optical densities at 8 and 
24 h.  
In terms of microorganism growth, the best data were obtained using soy peptone E110 
as nitrogen source. An absorbance of 4.5 was obtained after 8 h of growth; this value is 
kept constant through out the experiments, indicating the starting of stationary phase 
after 8 h.  
A similar trend was obtained for other experiments. Particularly, the growth with soy 
peptone A2SC and yeast extract was almost the same, being characterized by a final 
OD of 4.1 and 3.9, respectively. Similarly, the growth in MRS, vegetable peptone E1 and 
wheat peptone E430 gave very close OD values. Only using malt extract as complex 
nitrogen source, the biomass production was very low, with OD values of 0.9 (8 h) and 
1.1 (24 h). As far as the bacteriocin production is concerned, a maximum of activity was 
obtained for every culture after 8 h of growth, except when the microorganism was 
supplied of malt extract; in this case none bacteriocin production was detected. 
The best bacteriocin activity (80 BU·mL-1) was obtained in MRS, soy peptone A2SC and 
soy peptone E110. In terms of specific production (that gives the bacteriocin 
concentration produced per biomass unit), despite of a lower biomass production, 
utilization of soy peptone A2SC as nitrogen source allowed to obtain 20.5 BU·mL-1·OD-1, 
higher than the value obtained in the culture containing soy peptone E110. For this 
reason, soy peptone A2SC was selected as nitrogen source for the next growth 
experiments. A high specific production at 8 h (22.7 BU·mL-1·OD-1) was also detected 
when the microorganism was grown in MRS. 
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Nutrient 
 
OD (8 h) 
 
OD (24 h) 
 
BU·mL-1 (8 h) 
 
BU·mL-1·OD-1 (8 h)
 
Vegetable 
peptone E1 
 
3.5 
 
3.6 
 
40 
 
11.2 
 
Soy peptone 
A2SC 
 
3.8 
 
4.1 
 
80 
 
20.5 
 
Soy peptone 
E110  
 
4.5 
 
4.3 
 
80 
 
17.7 
 
Wheat peptone 
E430 
 
3.4 
 
3.5 
           
40 
 
11.4 
 
Yeast extract 
 
3.8 
 
3.9 
 
60 
 
15.4 
 
Malt extract 
 
0.9 
 
1.1 
 
0 
 
0 
 
MRS 
 
3.5 
 
3.5 
 
80 
 
22.7 
Table 7 
Comparison of growth parameters and bacteriocin activities in media 
containing different nitrogen complex sources.
Data of bacteriocin activity are in triplicates with standard deviation included between 5-10 %. 
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3.1.2 Effect of the carbon and nitrogen source concentrations  
 
Once selected the nitrogen complex source, flask experiments were also carried out to 
test the influence of reducing the concentration of carbon (glucose) and nitrogen (soy 
peptone A2SC) sources on the microorganism growth and enterocin activity. The basal 
concentration for both nutrients is 20 g·L-1 (Table 5). The microorganism growth was 
tested in media containing decreased concentrations for both nutrients, until to 5 g·L-1.  
Figure 3 shows the comparison of growth curves. As expected, the decreasing of 
nutrient concentrations, particularly the nitrogen source, has effect on biomass 
production. In fact, in media containing 20 and 10 g·L-1 of soy peptone A2SC, the final 
OD, measured at 24 h, ranges from 4.1 to 3.8, depending on the glucose concentration. 
A lower biomass production is obtained when the microorganism is grown with soy 
peptone A2SC 5 g·L-1, independently on the glucose concentration. Particularly, after 8 h 
of growth, the absorbance is very similar (about 2.8) for each experiments, while a slight 
decrease is observed for the culture containing 5 g·L-1 of both nutrients. 
The bacteriocin activity at 8 h was also detected in these cultures (Table 8). 
Interestingly, very similar bacteriocin activity was obtained, although the differences 
observed in the biomass production. An enterocin activity  of 80 BU·mL-1 was detected 
when soy peptone A2SC concentration was 10 or 20 g·L-1, while 60 BU·mL-1 were found 
in cultures grown with soy peptone A2SC 5 g·L-1. Despite this slight difference, higher 
values of specific production were obtained in poorer media. In particular, specific 
production of 22.9 BU·mL-1·OD-1 was measured for the culture grown in the medium 
containing 5 g·L-1 of glucose and soy peptone A2SC. For this high enterocin production 
per biomass unit, this medium was chosen as suitable for the following fermentations 
experiments.  
 
3.1.3 Flask experiments: L. plantarum DSM 12028 and L. crispatus L1 
 
In order to evaluate the effect of different bactocasitone concentrations on bacteriocin 
production by L. plantarum DSM 12028 and L. crispatus L1, flask experiments were also 
performed. Concentrations of 1, 5 and 10 g·L-1 of complex nitrogen source were tried. 
Table 9 reports the data obtained in terms of growth and bacteriocin production. For L. 
plantarum DSM 12028, the reduction of bactocasitone concentration from 10 to 5 g·L-1 
did not influence the growth and bacteriocin production: at 8 h, 40 BU·mL-1 were 
detected for both cultures. Bacteriocin specific production was generally similar.  
Differently from L. plantarum DSM 12028, the reduction of bactocasitone concentration 
from 10 to 5 g·L-1 in L. crispatus L1 cultivations determined a decrease of bacteriocin 
activity from 40 to 20 BU·mL-1, respectively.  
Lower biomass production (2.2 OD for L. plantarum DSM 12028 and 1.6 for L. crispatus 
L1) and no bacteriocin activity were detected in the experiments with 1 g·L-1 of 
bactocasitone. 
 
3.2 Fermentations experiments in batch modality 
  
3.2.1 Batch fermentations of E. casseliflavus CGA1 
 
Batch fermentations were performed to test the E. casseliflavus CGA1 growth on the  
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Medium 
 
BU·mL-1 (8 h) 
 
BU·mL-1·OD-1 (8 h) 
 
Soy-20/Gluc-20 
 
80 
 
20.6 
 
Soy-10/Gluc-20 
 
80 
 
21.1 
 
Soy-10/Gluc-10 
 
80 
 
21.6 
 
Soy-5/Gluc-20 
           
60 
 
23.0 
 
Soy-5/Gluc-10 
 
60 
 
22.6 
 
Soy-5/Gluc-5 
 
60 
 
22.9 
Figure 3 
Comparison of curves obtained growing E. casseliflavus CGA1 in media 
containing different concentrations of soy peptone A2SC and glucose (g·L-1). 
Table 8 
Comparison of the bacteriocin activities of the 
cultures in figure 3.
Data of bacteriocin activity are in triplicates with standard 
deviation included between 5-10 %. 
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Microrganism 
 
Scale 
 
Bactocasitone 
concentration  
( g·L-1) 
 
OD  
(24 h) 
 
BU·mL-1  
 
BU·mL-1·OD-1  
 
L. plantarum 
DSM 12028 
 
Flask 
 
10 
 
3.8 
 
40 
 
10.4 
 
L. plantarum 
DSM 12028 
 
Flask 
 
5 
 
3.6 
 
40 
 
11.0 
 
L. plantarum 
DSM 12028 
 
Flask 
 
1 
 
2.2 
 
0 
 
0 
 
L. crispatus L1 
 
Flask 
 
10 
 
2.6 
           
40 
 
15.3 
 
L. crispatus L1 
 
Flask 
 
5 
 
2.0 
 
20 
 
9.8 
 
L. crispatus L1 
 
Flask 
 
1 
 
1.6 
 
0 
 
0 
 
L. plantarum 
DSM 12028 
 
Batch 
 
5 
 
8.3 
 
120 
 
14.4 
 
L. crispatus L1 
 
Batch 
 
10 
 
6.0 
 
80 
 
13.3 
Table 9 
Growth and bacteriocin activities of L. plantarum CGA1 and L. crispatus in flask and 
batch fermentations. 
Data of bacteriocin activity are in triplicates with standard deviation included between 5-10 %. 
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optimized medium at a higher scale and to characterize the growth parameters, in terms 
of specific growth rate (μ, h-1) and yield coefficients Yxs (yield of biomass on substrate, g 
of biomass·g of substrate-1) and Yps (yield of product on substrate, g of product·g of 
substrate-1). The kinetics of enterocin and lactic acid production, and glucose 
consumption, were also characterized.    
Experiments were initially performed on the 2 L fermenter (Biostat CT). The comparison 
of growth curve and kinetics of glucose consumption and lactic acid production is 
reported in figure 4. From the plot you can see that the exponential phase ended after 6 
h of fermentation, when the OD value is 2.9, that corresponds to a biomass 
concentration of 1.5 g·L-1. A constant biomass concentration (stationary phase) was kept 
for the remaining fermentation time, with a little decrease detected at 24 h (X=1.4 g·L-1). 
The μ calculated for the exponential phase was 0.65 h-1, corresponding to a duplication 
time (td) of 1.06 h.     
As expected the glucose was completely consumed during the exponential phase, 
decreasing  averagely from 5 g·L-1 at 0 h to 0  g·L-1 at 8 h. The Yxs, calculated for this 
phase, is 0.22  g·g-1. As the glucose is consumed, lactic acid is produced as metabolic 
product of the glucose fermentation. After 6 h of fermentation, about 5 g·L-1 of lactic acid 
were produced with an average Yps of 0.83 g·g-1, demonstrating the homolactic 
behaviour of this microorganism.  
The bacteriocin activity was also evaluated in batch fermentations and the kinetics of 
production was characterized. In figure 5 the batch growth curve is compared with the 
activity of the enterocin, expressed in BU·mL-1. The plot shows how the peptide was 
produced during the exponential phase, thus reaching a maximum of 80 BU·mL-1 at the 
end of the active growth phase. Constant levels of product were kept as the culture is in 
early stationary phase. At 24 h, a decrease of activity to 60 BU·mL-1 was observed. 
 
3.2.2 Scale up of the batch experiments 
 
In order to evaluate the scalability and the reproducibility of the process on larger scales, 
batch fermentations were carried out on a 15 L fermenter (Biostat C) and a 100 L 
fermenter (Biostat D). The same conditions, in terms of medium composition, pH, stirring 
and temperature, were used.  
Table 10 reports the fermentation parameters and the bacteriocin activities for the three 
different scales. Only small variability can be found between the three fermentation 
processes. Particularly, the highest final biomass production was obtained in the 
intermediate scale (1.4 g·L-1), despite the lowest specific growth rate (0.63 h-1). Values 
of yield coefficients were comparable, ranging from 0.22 to 0.24 g·g-1 for Yxs and from 
0.79 to 0.88 g·g-1 for Yps. 
Interestingly, also the bacteriocin activities were very close. 15 and 100 liters cultures 
could produce 60 and 80 BU·mL-1 at 6 h, respectively. A decrease of bacteriocin activity 
was detected in late stationary phase (24 h ) for both fermentations as well as for the 
small scale one. In particular, a sharp decrease (from 80 to 30 BU·mL-1) was observed 
for the larger scale cultivations. 
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Figure 4 
Comparison of the growth curve for E. casseliflavus CGA1 in batch 
fermentation with glucose consumption and lactic acid production. 
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Culture volume 
(Fermenter) 
 
Final X 
(g·L-1) 
 
μ (h-1)
 
Yxs  
(g·g1)
 
Yps 
 (g·g-1) 
 
BU·mL-1  
(6 h) 
 
BU·mL-1  
(24 h) 
 
2 L (Biostat CT) 
 
1.38 
 
0.65 
 
0.22 
 
0.83 
 
80 
 
40 
 
15 L (Biostat C) 
 
1.42 
 
0.63 
 
0.24 
 
0.88 
 
60 
 
40 
 
100 L (Biostat D) 
 
1.39 
 
0.68 
 
0.23 
 
0.79 
 
80 
 
30 
Table 10 
Comparison of the batch fermentations on 2, 15 and 100 liters. 
Figure 5 
Growth curve of E. casseliflavus CGA1 in batch fermentation and enterocin 
production profile. 
Data of bacteriocin activity are in triplicates with standard deviation included between 5-10 
%. 
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3.2.3 Batch fermentations of L. plantarum DSM 12028 and L. crispatus L1 
 
Batch fermentations of L. plantarum DSM 12028 and L. crispatus L1 were carried out in 
order to study the bacteriocin production in a more controlled environment compared to 
flasks. The concentration of bactocasitone was 5 g·L-1 for L. plantarum DSM 12028 and 
10 g·L-1 for L. crispatus L1 fermentation.  
Table 9 summarizes the data obtained. In comparison with flask experiments, a 
significative improvement in terms of bacteriocin production was detected for L. 
plantarum DSM 12028: 120 BU·mL-1 were obtained after 8 h of growth. It corresponds to 
a specific bacteriocin production of 14.4 BU·mL-1·OD-1. For L. crispatus L1 batch 
fermentation allowed to double the bacteriocin activity (80 BU·mL-1). 
 
3.3 Fermentation experiments in fed-batch modality 
 
In order to obtain increased biomass production and, therefore, higher titer of enterocin, 
fed-batch fermentations were implemented and scaled up. Two kinds of fed-batch 
strategies, different for the mode of feeding of fresh medium into bioreactor, were 
performed and compared in terms of biomass production and bacteriocin activity: pulses 
feeding and continuous feeding.   
 
3.3.1 Pulses fed-batch experiments 
 
Pulses of fresh broth, containing every nutrient concentrated in order to provide, after 
the addition into the bioreactor, the initial concentration in the medium, were first carried 
out on 2 L fermenter. 
In “one pulse” experiment, the addition was performed at the end of the exponential 
phase, when the glucose was completely consumed (5 h), as determined in batch 
fermentations. In “two pulses” experiment, the additions were respectively done at 5 and 
7 h, when the first glucose addition was consumed. Finally, a third pulse was performed 
at 9 h in three pulses fed-batch. 
Figure 6 reports the comparison of the growth curves for these experiments. As 
expected, increasing the number of pulses, the exponential phase is prolonged and the 
biomass production is improved. Particularly, in the fermentation with three pulses, a 
final biomass concentration of 4.3 g·L-1, thus improving about three fold the biomass 
production obtained in batch.  
Bacteriocin activity was also improved: the maximum activity, detected after 11 h of 
fermentation for three pulses experiment, was 160 BU·mL-1. Moreover, in terms of 
specific production, there was not improvement (14.4 BU·mL-1·OD-1 against 26.6  
BU·mL-1·OD-1 obtained in batch fermentation; data not shown). 
 
3.3.2 Continuous feeding experiments and scale up 
 
Fed-batch experiments with continuous feeding of fresh concentrated medium into 
bioreactor were initially performed on 2 L scale. The feeding strategy was implemented 
through equations 1 and 2 (see Materials and Methods), using the data (Yxs, μ, qs) 
obtained from the analysis of batch fermentations and considering glucose as limiting 
substrate. In figure 7 the growth curve obtained with this fed-batch strategy is reported  
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Figure 6 
Comparison of the growth curve for E. casseliflavus CGA1 in pulses fed-
batch fermentation.  
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Figure 7 
Growth curve of E. casseliflavus CGA1 grown through fed-batch fermentation 
with continuous feeding and kinetics of enterocin production.
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and compared to the enterocin activity. The feeding started after 6 h of batch 
fermentation, when the glucose was completely consumed. The figure clearly shows as 
the developed feed profile allowed to prolong the exponential phase, thus increasing the 
biomass production. After 30 h of cultivation, the biomass concentration was 11.6 g·L-1. 
It corresponds to an improvement of 8.5 and 2.5 fold in comparison with batch and 
pulses fermentations, respectively. The specific growth rate, measured for the fed-batch 
phase (6-30 h), was 0.07 h-1. The Yxs was kept constant at 0.20 g·g-1, similar to the 
batch fermentations, through the fed-batch phase. 
Interestingly, the bacteriocin activity was strongly improved. In figure 7 you can see the 
peptide was produced as the biomass concentration increased, reaching a maximum 
activity of 640 BU·mL-1 after 22 h of fermentation. Then, the level of product is kept 
constant, while a decrease to 480 BU·mL-1 after 28 h of growth is observed. Considering 
the maximum bacteriocin concentration, a specific production of 30.4 BU·mL-1·OD-1 was 
obtained. 
This process was also scaled up on Biostat C and Biostat D fermenters. The data 
compared are reported in Table 11, showing a good reproducibility. In fact, very similar 
values of biomass concentration were obtained; only the cultivation in 100 L fermenter 
resulted in slightly lower yield, being characterized by a final cell concentration of 10.3 
g·L-1 against values of 11.6 and 12.5 g·L-1 obtained for 2 L and 15 L cultures, 
respectively. Furthermore, very close values of specific growth rate were obtained, 
ranging from 0.18 h-1 (for 100 L culture) to 0.21 h-1 (for 15 L culture). 
Very interestingly, the same bacteriocin production was detected, in a time interval from 
22 to 24 h. 
 
3.4 Downstream processes 
 
After fed-batch fermentation with continuous feeding on 2 L scale, the broth was 
processed in purification operations in order to recover the bacteriocin. Downstream 
processes based on buthanol/acetone, methanol/chloroform extraction or membrane 
processes were performed, as described in Materials and Methods. In every case, the 
cells were previously separated by centrifugation and the supernatant was recovered 
and ready to be further processed. 
Table 12 compares bacteriocin activities and yields detected in each fraction for the 
three downstream processes. The yields for each step are calculated comparing the 
activity of the step with the initial one in the supernatant (640 BU·mL-1). The protein 
concentrations (mg·mL-1) for each step and the increase in specific activity (BU·mg-1) are 
also reported.  
Using the buthanol/acetone protocol (Table 12a), a final bacteriocin concentration of 
1600 BU·mL-1 was obtained from the initial 640 BU·mL-1 of the supernatant. Considering 
the 10 fold concentration factor, this purification gave a yield of enterocin of 25 %. The 
increase in bacteriocin specific activity resulted in final 2285.7 BU·mg-1, that corresponds 
to a purification fold of 15. 
The final yield and purification fold obtained with choloroform/methanol procedure (Table 
12b) were 50 % and 11.6, respectively. The chloroform/methanol contained 3200 
BU·mL-1 of bacteriocin and 1.8 mg·ml-1 of residual proteins, corresponding to a specific 
activity of about 1780 BU·mg-1. 
For the membranes purification protocol, experiments to optimize the process  
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Culture volume 
(Fermenter) 
 
Final X 
(g·L-1) 
 
μ (h-1)
 
Maximum 
BU·mL-1  
(h) 
 
Maximum 
BU·mL-1·OD-1   
(h) 
 
2 L (Biostat CT) 
 
11.6 
 
0.19 
 
640 (22) 
 
30.4 
 
15 L (Biostat C) 
 
12.5 
 
0.21 
 
640 (24) 
 
31.2 
 
100 L (Biostat D) 
 
10.3 
 
0.18 
 
640 (22) 
 
31.0 
Table 11 
Comparison of fed-batch fermentations on 2, 15 and 
100.  
Data of bacteriocin activity are in triplicates with standard deviation included 
between 5-10 %. 
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Parameter 
 
Supernatant 
 
Buthanol 
extract 
 
Acetone 
precipitate 
  
BU·mL-1  
 
640 
 
3200 
 
1600 
 
mg·mL1 
 
4.9 
 
2.2 
 
0.7 
 
BU·mg-1 
 
152.3 
 
1454.5 
 
2285.7 
 
Purification fold 
 
0 
 
9.5 
 
15 
 
Yield (%) 
 
100 
 
50 
 
25 
 
Parameter 
 
Supernatant 
 
Ammonium 
sulphate 
precipitate 
 
Chloroform/m
ethanol 
extract 
  
BU·mL-1  
 
640 
 
4800 
 
3200 
 
mg·mL1 
 
4.9 
 
3.2 
 
1.8 
 
BU·mg-1 
 
152.3 
 
1500 
 
1777.7 
 
Purification 
fold 
 
0 
 
9.8 
 
11.6 
 
Yield (%) 
 
100 
 
75 
 
50 
 
Parameter 
 
Supernatant
 
Permeate (30 kDa)
 
Ammonium 
sulphate 
precipitate 
 
Retentate 
 (3 kDa) 
  
BU·mL-1  
 
640 
 
480 
 
4800 
 
9600 
 
mg·mL1 
 
4.9 
 
3.6 
 
2.1 
 
1.1 
 
BU·mg-1 
 
152.3 
 
133.3 
 
2285.7 
 
8727.2 
 
Purification fold 
 
0 
 
0.8 
 
15 
 
57.2 
 
Yield (%) 
 
100 
 
75 
 
75 
 
75 
 
Purification fold 
- 15 L 
 
0 
 
0.6 
 
11.2 
 
51.2 
 
Yield - 15 L  (%) 
 
100 
 
75 
 
75 
 
75 
Table 12 
Comparison of the downstream processes of the 
enterocin from fed-batch fermentation broth. 
(a) 
(b) 
(c) 
Data of bacteriocin activity are in triplicates with standard deviation included between 5-10 %. 
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parameters of the ultrafiltration step at 3 kDa were initially performed. These 
experiments were finalized to evaluate the best cross flow rate and TMP to perform the 
process, that are the conditions that maximize the permeate flux.  
Figure 8 reports, as result of these experiments, the plot of permeate flux versus TMP at 
the different retentate flows tested. The best conditions are the retentate flow and the 
TMP that maximize the flux, before the levelling of the curve: retentate flow of 200 
mL·min-1, corresponding to a cross flow rate of 14.2 lpm·m-2, and TMP of 1.25 bar.  
In Table 12c the results of set of experiments are summarized. The yield of the first step 
(30 kDa ultrafiltration) was 75 %. However the remaining steps did not cause further 
decrease of the product; in fact, no other losses were detected in the ammonium 
sulphate precipitation and 3 kDa diafiltration. Finally 9600 BU·mL-1 of enterocin were 
detected in the 3 kDa retentate, with a 20 fold concentration factor. In terms of specific 
activity, no improvement was obtained by the 30 kDa ultrafiltration (about 133 BU·mg-1), 
while a great increase was obtained in the next steps: 2285.7 BU·mg-1 for ammonium 
sulphate precipitation and 8727.2 BU·mg-1 for 3 kDa ultrafiltration. This corresponded to 
a final purification fold of over 57. 
The downstream processing based on membranes was also scaled up to a larger 
volume. In particular, the broth from Biostat C (15 L fermenter) was recovered and 
processed through this procedure. Table 12c reports the purification folds and the yields 
obtained. Despite of a lower specific activity of the ammonium sulphate step than the 
small scale precipitation, the 3 kDa ultrafiltration allowed to deeply purify the enterocin 
until to have a final purification of about 51 fold, very close to the value obtained in the 2 
L procedure (57.2). Both the recovery for each step and the final yield were the same 
(75 %).  
 
3.5  Determination of the enterocin molecular weight 
 
Ultrafiltration experiments on centrifugal filters with different cut offs were performed in 
order to identify the range of enterocin molecular weight. Supernatant of fed-batch 
fermentation was used at this aim (initial bacteriocin activity of 640 BU·mL-1). The activity 
of the fraction over 10 kDa was 160 BU·mL-1 (data not shown). A greater concentration 
(480 BU·mL-1) was detected in the fraction between 3 and 10 kDa. No activity was 
observed below 3 kDa. 
A further evidence that the molecular weight of the product ranges between 3 and 10 
kDa was obtained by tricine SDS-PAGE. Figure 9 shows the electrophoretic gel for the 
supernatant after batch fermentation, fed-batch fermentation with continuous feeding 
and purification through ultrafiltration steps. The picture shows as, after performing the 
downstream processing of the fermentation broth through membranes, only one protein 
band, corresponding to the enterocin (as demonstrated by the activity assay), is 
obtained. The molecular weight of the product, as showed by the electrophoretic gel, 
ranges between 4.5-5 kDa.  
 
3.6  Activity spectra  
 
The fermentation supernatants and the purified enterocin were tested against a number 
of Gram positive and Gram negative bacteria, using the agar well diffusion assay. The 
results are showed in Table 13. It can be seen that the enterocin has activity versus 7  
  
 65                    
 
 
 
 
 
 
 
 
0
5
10
15
20
25
30
35
0.50 0.75 1.00 1.25 1.50 1.75 2.00
Fl
ux
 [ 
LM
H
]
TMP [ bar]
50 mL/min 125 mL/min 200 mL/min
Fl
ux
 [ 
LM
H
]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8 
Optimization curves for 3 kDa ultrafiltration process at three different retentate 
flows. 3 kDa hollow fibers were used (filtering area=0.014 m2). 
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Figure 9 
Tricine SDS-PAGE of supernatant of the fed-batch fermentation (lane 1), 
supernatant of the batch fermentation (lane 2), product after membranes 
purification protocol (lane 4) and 2 fold concentrated product after membranes  
purification protocol (lane 5). Lane 3: molecular weight markers. 
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Microorganism  
target 
 
Gram 
 
Properties 
 
E. 
casseliflavus 
CGA 1 
 
L. plantarum  
DSM 12028 
 
L. crispatus 
L1  
 
 
Lactobacillus casei 
DSM 20011 
 
+ 
 
Dairy starter 
 
++ 
- - 
 
Lactobacillus 
bulgaricus DSM 
21081 
 
+ 
 
Dairy starter 
 
+ 
- - 
 
Lactobacillus 
crispatus L1 
 
+ 
 
Vaginal 
isolated with 
probiotic 
function 
 
+++ 
- // 
 
Lactobacillus 
plantarum DSM 
12028 
 
+ 
 
Meat starter  
 
- 
// - 
 
Lactococcus lactis 
NZ9000 
 
+ 
 
Dairy starter 
 
++ 
+ - 
 
Listeria 
monocytogenes 
 
+ 
 
Human 
pathogen  
 
+++ 
- - 
 
Staphilococcus 
aureus 
 
 
+ 
Human 
pathogen 
 
+ 
+++ +++ 
 
Streptococcus 
agalactiae 
 
 
+ 
 
 
 
Human 
pathogen 
- ++ ++ 
Enterococcus 
faecium 
 
 
+ 
Human 
pathogen 
+++ - - 
Klebsiella 
pneumoniae 
 
+ Human 
pathogen 
- + ++ 
Escherichia coli 
K4 
 
- Human 
pathogen 
- + ++ 
Escherichia coli 
BL21 
 
- Human 
pathogen 
- ++ + 
-= Absence of inhibition; + = Inhibition halo between 8 and12 mm; + + = Inhibition halo betwwen 12 and 16 mm;  
+ + + = Inhibition halo > 16 mm 
Table 13 
Spectrum activity of the bacteriocin produced by E. casseliflavus CGA1, L. 
plantarum DSM 12028 and L. crispatus L1 towards some Gram positive and 
negative bacteria.  
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out 12 tested microroganisms. Particularly, a great activity (inhibition halo over 16 mm) 
was detected versus strains of L. monocytogenes, Enterococcus faecium and 
Lactobacillus crispatus L1, while less inhibitory ability was observed versus the other 
microrganisms (inhibition halo under 16 mm). Besides L. monocytogenes, only 
Staphilococcus aureus was weakly inhibited, between pathogens tested. No inhibition 
was detected against Klebsiella pneumoniae, Streptococcus agalactiae and Escherichia 
coli strains tested. The probiotic strain L. plantarum DSMZ12028 was also not inhibited 
by the enterocin. An agar plate that shows the inhibition towards L. monocytogenes is in 
figure 10. 
The table also shows the inhibitory spectrum of Lactobacillus plantarum DSM 12028 and 
Lactobacillus crispatus L1. The first one was able to inhibit S. aureus (inhibition halo 
over 16 mm), S. agalactiae and E. coli BL21, while less activity was observed against K. 
pneumoniae, E. coli k4 and L. lactis NZ9000. L. monocytogenes and the other 
starter/probiotic strains tested were not inhibited. A similar activity spectrum was defined 
for L. crispatus L1. Particularly, a strong activity was detected versus S. aureus 
(inhibition halo over 16 mm). The pathogens S. agalactiae, K. pneumoniae, E. coli K4 
and E. coli BL21 were also inhibited. 
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Figure 10 
Agar well diffusion assay of the enterocin produced by 
E. casseliflavus CGA1 towards with L. 
monocytogenes. Clear halos indicate zones where the 
microorganism was inhibited.  
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4. DISCUSSION 
 
Lactic acid bacteria (LAB) are exstensively used in food processing, such as in dairy and 
meat fermented products for their contribution to shelf life, texture, and organoleptic 
functions (Wood B.J.B., 1997). Due to these properties, most of them are generally 
regarded as safe (GRAS) in  food production. These microorganisms have furthermore 
been used in food and feed preservation for centuries since they can produce a variety 
of antimicrobial agents, including organic acids like lactic and acetic acid, ethanol, 
carbon dioxide, diacetyl, and hydrogen peroxide (Holzapfel et al., 1995). Additionally, 
many LAB produce a high diversity of different bacteriocins (Cleveland et al., 2001). 
Bacteriocins are antibacterial peptides or proteins produced by bacteria that kill or inhibit 
the growth of other microorganisms, particularly strains closely related to the producer 
one. Most of them are found in numerous fermented and non-fermented foods, e.g. 
meat, fish, dairy products and vegetables. Furthermore, some of them inhibit spoilage 
bacteria and food-borne pathogens including Listeria monocytogenes, Staphylococcus 
aureus, and Clostridium botulinum. For this reason, the use of either bacteriocins 
produced by LAB strains as food preservative or the bacteriocin-producing LAB starter 
cultures has received a special attention as a new preservation method to control 
pathogenic bacteria, based on a completely “natural” approach. The number of research 
papers on this topic is increasing all over the world. However, though many bacteriocins 
have been biochemically and genetically characterized and there is basic understanding 
of their structure-function, biosynthesis, and mode of action, though many factors 
influencing their production in food systems are clarified, nisin, a lantibiotic produced by 
Lactococcus lactis ssp. fermentation, is currently the only bacteriocin actually used as 
food preservative. The reason for this resides primarily in the lack of suitable and 
economically convenient processes for bacteriocin production on industrial scale, in 
terms both of fermentative processes and adequate purification procedures. Indeed, for 
effective commercial application, production processes have to be optimized, by 
establishment of the optimal conditions for growth and bacteriocin production and 
recovery. 
The aim of the present work was to study the production of bacteriocins from three LAB 
stains (Enterococcus casseliflavus CGA1, Lactobacillus plantarum DSM 12028 and 
Lactobacillus crispatus L1) assaying their ability to inhibit pathogenic microorganisms 
and developing productive processes scalable for an industrial application. Particularly, 
for one of these strains, belonging to Enterococcus genus and obtained by an industry 
active in food processing, a fermentative process aiming to bacteriocin production was 
optimized and scaled up to a pilot plant. Also the downstream processing to purify the 
product from fermentation broth was developed. 
Among LAB genera, enterococci frequently occur in some cheeses and meats, 
particularly in those produced in Mediterranean countries (Sarantinopoulos et al., 2002). 
They are considered as either a natural starter culture or a contamination from the 
environment, contributing to the development of the organoleptic properties of the food. 
Very interestingly, bacteriocin-producing enterococci are widespread in nature and have 
been isolated from numerous sources (Giraffa G., 1995), such as dairy products, 
fermented sausages, fish, vegetables, and the mammalian gastrointestinal tract. Several 
enterococcal bacteriocins (enterocins) have been characterized at the molecular level 
and identified as generally belonging to class II and having the potential to inhibit the 
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growth of a narrow range of pathogenic strains, above all Listeria monocytogenes ssp. 
(Sabia et al., 2003). For this reason, bacteriocins produced by enterococci might be 
good candidates for potential application of bacteriocin-mediated antagonism against L. 
monocytogenes in foods. 
Enterococcus casseliflavus CGA1, purchased by the industry to our research center, 
has been isolated by “salami” meat and delivered to characterize its ability to produce an 
enterocin active towards Listeria monocytogenes. In attempt to develop a productive 
process for this bacteriocin scalable on an industrial level, first the medium for 
microorganism growth and enterocin production was optimized. It’s widely reported in 
literature that bacteriocin production from LAB is strongly influenced by several factors, 
mainly cultural conditions, such as pH, temperature and medium composition (Parente 
and Ricciardi, 1999).  
As far as the medium composition is concerned, rich and complex media as MRS give 
highest yields of bacteriocin. For example, high bacteriocin levels were obtained by 
Lactobacillus plantarum strains ST23LD and ST341LD grown in MRS medium (Todorov 
and Dicks, 2006). Futhermore, the addition of complex sources, as tryptone, yeast 
extract and meat extract, could significantly improve the bacteriocin production. Similarly 
the addition of yeast extract to a medium based on milk improved the bacteriocin 
production by some LAB strains (Avonts et al., 2004). High bacteriocin levels were 
obtained from a number of LAB strains grown in media based on MRS (Leroy and De 
Vuyst, 2002; Leal-Sánchez et al., 2002). Despite the high bacteriocin production, these 
media are expensive and, therefore, not suitable for industrial applications. In order to 
evaluate the effect of medium composition on enterocin production from E. casseliflavus 
CGA1, flask experiments were performed. The microrganism was grown in MRS and in 
a basal medium, whose composition was suggested by our industrial partner (Table 5), 
added with different industrial complex sources. Being the bacteriocin a peptide, the use 
of nitrogen nutrients with different compositions and concentrations of several amino 
acids and low molecular weight peptides could have influence on the bacteriocin 
production, besides the microorganism growth. Indeed, the growth and the bacteriocin 
production in presence of some sources, as soy peptones and yeast extract, was better 
than in presence of other ones, as malt extract. Particularly, a bacteriocin activity of 80 
BU·mL-1 was obtained with the two soy peptones tried. In terms of bacteriocin specific 
production, that is the bacteriocin activity produced per biomass unit, the best result was 
20.5 BU·mL-1·OD-1, obtained when the medium was added with soy peptone A2SC. 
These results demonstrate that the medium composition, and mainly the kind of 
complex nitrogen source, has effect on the bacteriocin production from LAB. The 
absence of bacteriocin activity detected in the medium added with malt extract may be 
explained considering that this nutrient is primarily constituted by carbohydrates, rather 
than amino acids and peptides. As expected, a good result was also obtained in the 
growth experiment with MRS. After 8 h of growth, also 80 BU·mL-1 were detected, but 
the specific bacteriocin production was better (22.7 BU·mL-1·OD-1) than the growth in 
soy peptone A2SC. As anticipated before, the drawbacks of using rich media as MRS 
for an industrial implementation reside in a high cost, and in the complexity of their 
composition, with consequent problems related to easy growth of other microorganisms 
and to eventual contamination in the purification procedure. On the contrary, the 
medium supplied with soy peptone A2SC is a cheaper medium at known composition, 
able to give good enterocin production by E. casseliflavus CGA1. 
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In order to further reduce the cost of the medium, other flask experiments were carried 
out. Different combinations of glucose (carbon and energy source) and soy peptone 
A2SC concentrations from 20 to 5 g·L-1 were assayed. As expected, an influence on 
biomass production was observed, but it mainly depended on the soy peptone A2SC, 
further demonstrating the key importance of the complex source for the growth of 
fastidious microorganisms as LAB. Particularly, the reduction of this nutrient from 20 to 
10 g·L-1 did not influence greatly the biomass production, while the further decrease to 5 
g·L-1 has effect: at 8 h (last point of exponential phase), the OD value is about 2.8 every 
time that soy peptone A2SC concentration is 5 g·L-1, independently if glucose 
concentration is 5, 10 or 20 g·L-1. Only at 24 h, a reduction of biomass to an OD value of 
2.5 is observed in the medium with 5 g·L-1 for both glucose and soy peptone A2SC, 
indicating that the absence of the carbon and energy source for maintenance reactions 
can cause the starting of cell lysis in late stationary phase. Of course, the depletion of 
nitrogen source has influence on bacteriocin production, that goes down to 60  BU·mL-1 
when soy peptone concentration is 5 g·L-1 against the initial 80 BU·mL-1. This effect can 
be explained considering the proteinaceous nature of the enterocin and the lower 
biomass production. Interestingly, the bacteriocin production per biomass unit is greater 
in the media containing low concentrations of soy peptone A2SC and glucose (22.9 
BU·mL-1·OD-1), and very close to the specific production obtained in MRS. The reduction 
of glucose and complex source from 20 to 5 g·L-1 has two main beneficial effects on the 
development of the process: on one side, a significant drop of the fermentation medium 
cost is obtained; on the other one, the downstream processing is facilitated because 
less impurities have to be removed, above all considering that soy peptone is a source 
of peptides, potential contaminants of the product.     
The next step in process development was the study of the microorganism growth and 
enterocin production in fermenters operating in batch modality. Batch fermentations 
have been often used to understand the correlation between bacteriocin production and 
cultural conditions, e.g. pH and temperature, and to characterize the kinetics of 
bacteriocin production. For example, Parente and co-workers (1997) demonstrated how 
the bacteriocin production by Enterococcus faecium DPC1146 is strictly dependent on 
the growth phase, starting as soon as the cell growth begins and ceasing immediately at 
the end of exponential phase. A similar trend of production was observed for most of the 
bacteriocins produced by LAB grown in bach modality. Also the production of enterocin 
from E. casseliflavus CGA1 follows a typical kinetics of primary metabolite. The peptide 
production starts in concomitance with the starting of the exponential phase, thus 
reaching a maximum of 80 BU·mL-1 at the end of it. This value is kept constant during 
the stationary phase. At 24 h, a decrease of activity to 60 BU·mL-1 is observed. This 
drop is very often observed for bacteriocin production and can be explained as a result 
of bacteriocin degradation by specific or non specific proteases (De Vuyst and 
Vandamme, 1992), protein aggregation with consequent loss of activity and pH-
dependent adsorption of the bacteriocin molecules to the membrane of the producer 
cells (Yang et al., 1992). The optimal pH for E. casseliflavus CGA1 is 7; and it has been 
observed that the adsorption of bacteriocins to cells is maximal at neutral pH and 
decreases at low pH. On the other hand, no reduction of bacteriocin titre was observed 
when fermentations were carried out without pH control (Yang and Ray, 1994). In 
comparison with flask experiments, the biomass production was the same but the 
exponential phase ended earlier (higher specific growth rate) and a slight improvement 
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of bacteriocin activity was detected, as expected growing the microorganism in a more 
controlled environment. 
Besides the characterization of bacteriocin production, batch fermentations allowed to 
evaluate the profile of biomass and lactic acid production on glucose. Biomass yield of 
on glucose (Yxs) was 0.22 g·g-1, typical for a microorganism with fermentative 
metabolism, while the yield of lactic acid on glucose (Yps) was 0.89 g·g-1, demonstrating 
the homolactic character of the microorganism when grown on glucose. In fact, Yps of 
0.70-0.95 g·g-1 are tipically observed when LAB degrade glucose through homolactic 
fermentation, producing lactic acid as main by-product. 
A crucial step in the optimization of a bioprocess is represented by the implementation 
on higher scale, this is needed to support the feasibility of an industrial process. The 
three main scales for bioprocess development are laboratory (1-100 L), pilot plant (100-
1000 L) and production (more than 1000 L), but some authors include in this 
classification also the shake flask scale (Votruba and Sobotka, 1992). For 
biotechnological processes, the scale up ratio is typically about 1:10 up to 100000 L but 
lower ratios of about 1:5 often have been used to increase comfort levels (i.e., 
decreased risk of unexpected performance on scale up). The starting point to scale up a 
biotechnological process is the maintenance of identical operating conditions (usually 
assuming that there is geometrical similarity). Batch fermentations of E. casseliflavus 
CGA1 on the optimized medium were performed on three different volumes (2, 15 and 
100 L), using a scale up ratio of 1:10 and maintaining the same operating conditions and 
bioreactor configuration. Very interestingly, this linear scale up strategy allowed to obtain 
a good reproducibility of the data, in terms of bacterial growth (biomass production and 
specific growth rate) and  yields on glucose (Yxs and Yps). Very similar bacteriocin 
production kinetics, with a peak at the end of exponential phase and a decrease in late 
stationary phase, was also detected. Therefore, no need to change operating 
parameters or reduce the scale up ratio was taken in consideration.  
In attempt to obtain higher enterocin productions, fed-batch strategies were 
implemented. Differently by batch fermentations, where the bacteriocin production 
ceases at the end of growth phase and the yield is usually low, fed-batch fermentation 
technology allows to obtain high cell densities through the supply of fresh medium and, 
therefore, as bacteriocins are growth-related metabolites, higher bacteriocin titer 
(Callewaert and De Vuyst, 2000). In particular, an improvement of biomass production of 
E. casseliflavus CGA1 was observed in pulses fed-batch experiments: as expected, 
increasing the number of pulses, the final biomass concentration also increases, 
reaching 4.3 g·L-1 in the experiment with three additions, that corresponds to a three fold 
improvement in comparison with the biomass production obtained in batch. Interestingly, 
a lower bacteriocin specific production (14.4 BU·mL-1·OD-1 against 26.6 BU·mL-1·OD-1 
obtained in batch fermentation) was detected, indicating that the increase in biomass 
does not corresponds to a proportional increase in bacteriocin amount. 
In order to improve the bacteriocin specific production through fed-batch fermentations, 
a different strategy of medium addition, based on continuous feeding into bioreactor, 
was developed using the data of yield and glucose consumption obtained by the 
analysis of batch fermentations. A real increase in biomass production was obtained, 
improving batch and pulses fed-batch fermentation of about 8 and 2 fold, respectively. 
The difference in feeding modality has also influence on bacteriocin production. After 22 
h of fermentation  640 BU·mL-1 are produced, corresponding to a 8 fold improvement of 
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the batch activity and a bacteriocin specific production of 30.4 BU·mL-1·OD-1. Even tough 
the culture slightly continues to grow, a decrease of bacteriocin activity after 28 h of 
growth is observed, probably due to pH-dependant adsorption phenomena to the 
producer cell membrane. 
Fed-batch technology based on continuous feeding are already used to improve the 
production for some bacteriocins. For example the production of amylovorin L471 by 
Lactobacillus amylovorus DCE 471 was improved in fed-batch fermentation if substrate 
addition is controlled by acidification rate of the culture (Callewaert and De Vuyst, 2000). 
In a similar study, a fed–batch strategy based on exponential feeding was used to 
improve the bacteriocin production by Lactobacillus curvatus CWBI-B28 (Ghalfi et al., 
2007). Despite the increase of the bacteriocin levels, the drawback of these fed-batch 
processes is the use of very rich media, both for batch (MRS containing addition of 
glucose and of different complex nitrogen sources) and fed-batch phase (high 
concentrations of glucose and complex nitrogen sources).  
The robustness of the developed fed-batch strategy was confirmed in linear scale up 
experiments until pilot plant of 100 L. Very interestingly, the same maximum bacteriocin 
activity was obtained (640 BU·mL-1) in a time interval between 22 and 24 h. These 
experiments demonstrate the suitability of the developed process for the implementation 
on an industrial scale.   
After fermentation, the product has to be recovered in order to have high purity and 
yield. The purification phase represents very often the most expensive step of the whole 
production process. The optimization of the downstream procedure is therefore essential 
to develop an applicable and cost effective process. Very few processes have been 
developed to purify bacteriocins from fermentation broths. Generally, bacteriocins are 
purified by subsequent centrifugation, ammonium sulphate precipitation and one or 
more chromatographic steps (Carolissen-Mackay et al., 1997). Although these 
procedure function reasonably well when small quantities of peptide have to be purified 
from a small (<1-liter) bacterial culture, they tend to become unmanageable for the large 
volumes needed for industrial production. In order to overcome this problem, 
downstream processes based on utilization of large amounts of organic solvents for 
precipitation and extraction operations, as buthanol, acetone or chloroform, have been 
developed. Although solvents may avert most of impurities from the broth, they are very 
expensive and also legal and security constraints should be considered for the 
bacteriocin purification from fermentation broths. These drawbacks make these 
procedures not suitable for industrial scale applications.  
In order to avoid the use of organic solvents, our objective was to design and develop an 
innovative downstream process based on the tangential flow filtration (TFF) technology. 
This technology is increasingly being exploited in recovery schemes for biotechnological 
products. Its applications range from bacterial and mammalian cells harvesting and virus 
removal to concentration of proteins and nucleic acids and buffer exchange applications 
(van Reis and Zidney, 2001). Processes based on membranes take advantage of their 
selectivity, high capacity and very low environmental impact. Furthermore, they are very 
well suited to the processing of biological molecules since they operate at relatively low 
temperatures and pressures and involve no phase changes or chemical additives, 
thereby minimizing the extent of denaturation, deactivation, and/or degradation of 
biological products. Finally, TFF cartridges may be used in numerous cycles and linearly 
scalable devices are commonly manufactured. 
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The downstream processing based on membranes we developed consisted of two 
ultrafiltration steps. The first one is a purification on 30 kDa membranes of the cell-free 
fermentation broth by large impurities, as cell debris or proteases active towards the 
peptide. The enterocin, having a low molecular weight, passes through the membrane 
and is recovered in the permeate. After an ammonium sulphate precipitation, a 
concentration and diafiltration step to remove the salts and low molecular weight 
impurities and obtain the peptide in purified water is performed on 3 kDa membranes. 
This last process was properly optimized in terms of TMP and cross flow rate that 
maximize the permeate flux. A permeate flux of 35 LMH was obtained at not drastic 
conditions of TMP and recirculation flow rate. Although the cut-off of the membrane is 
small, this reasonably high flux can be explained considering the relatively high purity of 
the product at this point of the downstream processing. 
The developed purification procedure was compared with a consolidated protocol of 
extraction/purification based on buthanol/acetone and a procedure based on 
chloroform/methanol reported in literature (Callewaert et al., 1999; Foulquié Moreno et 
al., 2003). Using the buthanol/acetone strategy, only the 25 % of the product was 
recovered, with a final purification fold of 15. Both buthanol extraction and acetone 
prepicipation were characterized by product losses. A better enterocin yield (50 %) was 
obtained with the chloroform/methanol procedure, despite of a low purification factor 
(11.6), indicating as this strategy is not selective for the product of interest. The resuts 
obtained show as these procedures are not suitable for a real and cost effective 
industrial application. On the contrary, when the procedure based on membranes was 
used to recover the enterocin, a final yield of product of 75 % was achieved. 
Furthermore, a greater final concentration factor (20 fold) and a relatively high 
purification fold of 57.2 were obtained, in comparison with procedures based on organic 
solvents. The purity of the product after this purification was clearly showed by tricine 
SDS-PAGE: only one protein band is obtained at a molecular weight of 4.5-5 kDa.  
Losses of product were observed in the 30 kDa ultrafiltration step: although the 
bacteriocin has a low molecular weight, part of product molecules pool is retained in the 
concentrate. This retention can be explained considering the following phenomena: 
aggregation of the peptide molecules forming high molecular weight polymers and 
interactions between the peptide and/or the aggregates and the membrane material at 
the surface or wiithin the pores. Bhugaloo-Vial and co-workers (1997) observed 
retention of divercin on 60-80 kDa membranes in a bioreactor coupled to the 
microfitration. They explained this behaviour hypotizing the formation of large complexes 
of bacteriocin in the fermentation conditions. Also helveticin J was produced as a 
complex superior to 300 kDa in culture supernatants while the purified product was a 
protein of 37 kDa (Joerger and Klaenhammer, 1986). Acidocin B activity was found at 
approximately 100 kDa when purified through gel permeation (Barefoot and 
Klaenhammer, 1984). The high apparent molecular weight of crude acidocin B resulted 
from the occurrence of large aggregates in the fermented MRS broth.  
Interestingly, no losses were detected in the next ammonium sulphate precipitation, 
differently from the chloroform/methanol procedure, where losses of product of 25 % 
occurred. That could be explained considering that the preceding ultrafiltration step 
removes impurities that interfere with the precipitation, e.g. aggregates between 
bacteriocins and/or bacteriocins and cell components that do not precipitate. 
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The downstream processing based on membranes was also scaled up on the 15 L 
scale. The final yield was the same. In terms of purification from proteins, only the 
ammonium sulphate precipitation gave a worse result, while the two ultrafiltration steps 
were perfectly reproduced. These results show the potentiality of the developed 
procedure to be transferred on an industrial scale, expecting the same performance 
obtained on laboratory scale.  
The purified product was used to characterize the activity spectrum of E. casseliflavus 
CGA1 versus pathogenic and beneficial microorganism. Very interestingly, strong 
activity versus Listeria monocytogenes was detected. Between the non-pathogenic 
strains, only Lactobacillus plantarum DSM 12028, a meat starter isolated by “salami”,  
was not inhibited. These two results are very comforting for the final objective of the 
project, that is the application of the enterocin as meat preservative to control the 
contamination by pathogens as L. monocytogenes. Of course, it is critical that the 
product does not have inhibitory activity towards beneficial and naturally occurring 
microorganisms of the food, as L. plantarum strains.  
The same microorganisms tested for defining the spectrum activity of E.casseliflavus 
CGA1 were used to assay the inhibitory activity of two LAB belonging to Lactobacillus 
genus: Lactobacillus plantarum DSM 12028 and Lactobacillus crispatus L1. The first 
one, isolated by meat, as above mentioned, was able to strongly inhibit Staphilococcus 
aureus, typical food pathogen, and, at a lower extent, other pathogens, as 
Streptococcus agalactie and Escherichia coli BL21. The same activity towards S. aureus 
was detected for L. crispatus L1, vaginal isolated with probiotic function. S. agalactiae, 
Klebsiella pneumoniae and E.coli K4 were also inhibited at a good extent. No activity 
towards L. monocytogenes was observed for the two strains. Differently from E. 
casseliflavus CGA1, the lactobacilli were able to inhibit Gram negative E. coli strains, in 
presence of EDTA. This chelating agent is able to sequestrate bivalent ions, e.g. 
magnesium, from lypopolysaccharidic layer of Gram negative bacteria outer membrane, 
destabilizaing it and allowing the antimicrobial peptide to carry out its action (Haque and 
Russel, 1975). For their action towards different pathogenic microorganisms, bacteriocin 
produced by L. plantarum DSM 12028 and L. crispatus L1 seem to have promising 
application in the field of biological preservation of foods. 
Therefore, flask experiments were performed to study the effect of different 
concentrations of bactocasitone (complex nitrogen source tipically used in media to 
cultivate lactobacilli, Kimmel and Roberts, 1998). For both microorganisms, no 
bacteriocin activity was detected when the concentration of bactocasitone was 1 g·L-1, 
indicating as high amounts of complex nitrogen source are required to have a basal 
production of bacteriocin. 5 g·L-1 are sufficient for L. plantarum DSM 12028 to have 40 
BU·mL-1 while 10 g·L-1 are required for L. crispatus L1 to have the same bacteriocin 
activity. The latter case is a demonstration that conditions that improve growth also 
support the bacteriocin production.  
Batch experiments were performed in order to evaluate the effect of controlled growth 
conditions on bacteriocin production from the two Lactobacillus strains. Improving the 
biomass production, also the bacteriocin activity was significantly improved, particularly 
for L. plantarum DSM 12028. In this case, the bacteriocin activity was improved three 
fold, along with specific production (14.4 BU·mL-1·OD-1). On the contrary, a slight 
decrease of specific production in comparison with flask experiments was detected for L. 
crispatus L1. The data obtained, particularly for L. plantarum DSM12028, confirm the 
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impression that this microorganism could be a good candidate as bacteriocin-producing 
strain, potentially applicable in food preservation. 
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CONCLUSIONS 
 
Three LAB strains were screened to evaluate their ability to produce bcateriocins 
potentially interesting in food industry. For one of them (Enterococcus casseliflavus 
CGA1), able to produce a peptide active towards Listeria monocytogenes, a 
biotechnological process for production and recovery of the molecule, based on modern 
fermentation and purification technologies, was developed. The research work has 
addressed towards different aspects of the process optimization. First, studies on flask 
scale allowed to identify the composition of a suitable medium for microorganism growth 
and bacteriocin production, then batch and fed-batch fermentation techniques have 
been exploited to enhance the production and finally scale up studies have been carried 
out until a pilot plant fermenter. Contemporary, in order to find a suitable purification 
process, an innovative downstream procedure based on utilization of ultrafiltration 
technology was developed and compared with traditional strategies. All the experiments 
indicated that the biotechnological production of the enterocin may be possible. Other 
experiments need to be performed to test the effective inhibitory action of the purified 
product in the food system. 
In addition, two lactobacilli strains, Lactobacillus plantarum CGA1 and Lactobacillus 
crispatus L1, were proved able to produce antimicrobial agents towards some 
pathogenic microorganisms. Bacteriocin production from these strains was studied 
through flask and batch experiments, demonstrating their potentiality as producers of 
interesting bacteriocins for food industry. 
 
 
 
.    
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